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ABSTRACT 
The polar bear (Ursus maritimus) is currently listed as a vulnerable species by the IUCN 
red list, mainly due to the predicted decline in sea ice caused by global warming. Polar bears 
are dependent on sea ice for hunting their main prey, the ringed seal (Phoca hispida). 
Shrinkage of sea ice can result in energetic challenges and increased mortality rates in polar 
bear populations, as their access to prey declines and the seasonal fasting period gets 
prolonged. Also affecting polar bears is the exposure and accumulation of persistent organic 
pollutants (POPs) to unusually high levels due to their lipid rich diet. Some POPs act as 
endocrine disrupting chemicals (EDCs), leading to metabolic disruption. EDCs may interact 
with nuclear receptors (NRs), including NRs involved in regulation of metabolism and 
adipogenesis, e.g. peroxisome proliferator-activated receptor gamma (PPARγ). Interference 
by environmental contaminants on NRs regulating adipogenesis in polar bear may affect 
lipid metabolism and thereby decrease their ability to respond to climate change. 
The aim of this thesis was to develop an in vitro method for studying effects of 
environmental contaminants on adipogenesis in polar bear by using adipose tissue-derived 
stem cells derived from polar bear (pbASCs). PbASCs were successfully maintained and 
propagated in culture and shown to have adipogenic potential when cultivated with 
adipogenic inducers. Lipid content (Oil red O staining) and transcript levels of the adipocyte 
specific genes PPARγ, fatty acid-binding protein 4 (FABP4) and leptin (LEP) were used to 
monitor differentiation of pbASCs. While lipid accumulation and transcript levels of PPARγ 
and FABP4 reflected the degree of adipogenic differentiation, transcript levels of LEP 
apparently did not reflect adipogenic differentiation, indicating that LEP may not be a 
suitable target gene for investigating adipogenic induction in pbASCs.  
Exposure of pbASCs with known EDCs demonstrated that mono(2-ethylhexyl)phtalate 
(MEHP) induced adipogenesis, while bisphenol A (BPA) did not.  
This study has established an in vitro method for investigating effects of environmental 
contaminants on adipocyte differentiation of pbASCs, by quantification of lipid content and 
transcript level analysis. The use of pbASCs as an in vitro model for effects of environmental 
contaminants on adipogenesis can provide valuable information on how contaminant 
exposure can affect energy homeostasis in the polar bear. 
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ABBREAVTIONS 
Abbrevations Full name 
A Adenosine 
AGE Agarose gel electrophoresis 
AIM Adipogenic induction medium  
ASCs Adipose tissue-derived stem cells 
BFR Brominated flame retardant 
BMSC Bone marrow-derived stem cells 
BPA Bisphenol A 
BSA Bovine serum albumin 
C/EBP CCAAT-enhancer-binding protein  
cAMP Cyclic AMP 
cDNA Complementary DNA 
ddNTPs Dideoxynucleotides 
DDT Dichlorodiphenyltrichloroethane 
DEHP Di(2-ethylhexyl)phthalate  
DEX Dexamethasone 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTPs Deoxynucleotides 
EDC Endocrine disrupting chemical 
EtBr Ethidium bromide  
FABP4 Fatty acid-binding protein 4 
GF1 Insulin-like growth factor 1 
GR Glucocorticoid receptor  
IBMX 3-Isobutyl-1-methylxanthine  
INDO Indomethacin 
ISCT The International Society for Cellular Therapy  
LB Lysogeny broth 
LBD Ligand binding domain 
LEP Leptin 
MSC Mesenchymal stem cells  
NR Nuclear receptor 
PBS Phosphate buffered saline 
PCB Polychlorinated biphenyl 
PCR Polymerase chain reaction 
POP Persistent organic pollutant  
PPAR Peroxisome proliferator-activated receptor  
PPIA Cyclophilin A 
PREF-1 Preadipocyte factor 1 
PVC Polyvinyl chloride  
RNA Ribonucleic acid 
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ROSI Rosiglitazone 
rRNA Ribosomal RNA  
RT Room temperature  
SD Standard deviation 
SVF Stromal vascular fraction  
TBE Tris-borate-EDTA 
U Uridine 
UV Ultraviolet 
V Volt 
WAT White adipose tissue 
YWHAZ Tyrosine 3/tryptophan 5-monooxygenase activation protein  
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1 INTRODUCTION 
1.1 POLAR BEARS FACE ANTHROPOGENIC CHALLENGES 
Wilcove et al. (1998) suggested that “habitat loss is the single greatest threat to 
biodiversity”.  In the Arctic the sea ice constitutes the habitat of several arctic animals, but 
it is currently rapidly declining due to global warming (Comiso et al., 2008). 
The polar bear (Ursus maritimus) is highly adapted to the arctic environment and is 
currently listed as a vulnerable species by the IUCN Red List (www.iucnredlist.org), due to 
predictions which estimate a minimum 30 % reduction in the polar bear population within 
45 years. This reduction is mainly due to the predicted decline in sea ice, but other stress 
factors include environmental pollutants, shipping, and oil and gas exploration (Schliebe et 
al., 2008, Amstrup et al., 2008, Durner et al., 2009). As stress factors can affect polar bear 
health, reproduction and survival, and in turn population levels, it is important to gain 
detailed knowledge about the effect of these factors, and how they may interact with each 
other (Fig. 1.1.) (Jenssen et al., 2015).  
An introduction to how climate warming and environmental pollution can affect the 
vitality of polar bears is provided, as these are the two factors relevant to understand the 
background of this study. 
 
Figure 1.1. Anthropogenic stressors may affect polar bears on population level. The figure 
illustrates how climate warming and environmental pollution can interact to affect polar bear 
survival, reproduction and health, on both individual and population level (figure from Jenssen et al, 
2015). 
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1.1.1 DECLINING SEA ICE POSES A THREAT TO POLAR BEARS 
The polar bear is especially sensitive to climate warming as it is dependent on sea ice for 
hunting seals, and performing seasonal migration between summer and winter habitats 
(Laidre et al., 2008). Vast areas of sea ice melts during summer, leaving polar bears with 
scarce access to food. To survive they must go through a seasonal fasting period which may 
last for up to eight months, by which the polar bears can lose up to 43 % of their body mass 
(Atkinson and Ramsay, 1995). During spring polar bears consume vast amounts of blubber 
by feasting on their main prey, the ringed seal (Phoca hispida), which they capture on land-
fast ice or drifting pack-ice (Derocher et al., 2002). The consumed energy is stored as fat 
reserves in white adipose tissue (WAT), and utilized during the seasonal fasting period. To 
avoid potentially fatal protein loss it is crucial that the polar bear has enough fat stored to 
cover the energy expenses, as over 90 % of the energy used during the fasting period 
originates from stored fat (Atkinson and Ramsay, 1995, Atkinson et al., 1996). Previous 
studies have shown that pregnant polar bears and their cubs are especially at risk during the 
seasonal fasting, and that the reproductive capability decreases with lower body fat content 
in female polar bears (Robbins et al., 2012, Rode et al., 2010). 
As a consequence of decline in sea ice, polar bears’ food availability is reduced and thus 
they may not be able to store enough fat reserves to survive the fasting season. Another 
consequence of the shrinking sea ice is that polar bears may walk and swim more to access 
their prey, which results in a higher energy expenditure for capturing prey (Derocher et al., 
2004). 
Climate warming is predicted to result in increased energetic challenges and mortality 
rates in polar bear populations, as winter habitats where the polar bear can hunt will decline, 
while the seasonal fasting period during summer will increase (Durner et al., 2009, Amstrup 
et al., 2008, Molnar et al., 2010). Also, a reduced reproductive success due to climate change 
has already been shown in some subpopulations (Stirling and Derocher, 2012). Fasting is 
physiologically stressful, and an optimal control of metabolism is needed to maintain a 
sufficient supply of energy to all organs. Exposure to contaminants has been shown to 
interfere with energy metabolism, for example through the nuclear receptor (NR) 
peroxisome proliferator-activated receptor gamma (PPARy) (Casals-Casas and Desvergne, 
2011, Feige et al., 2006). Thus, it is possible that exposure to contaminants can add to the 
increased mortality rates and decreased reproductive success induced by the prolonged 
fasting period, as hypothesized by Jenssen et al. (2015). 
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1.1.2 PERSISTENT ORGANIC POLLUTANTS IN POLAR BEARS 
Persistent organic pollutants (POPs) are organic chemicals characterized by a distinct set 
of properties, such as having a long degradation time in the environment. These chemicals 
can be transported over long distances by wind or ocean currents. They are also lipophilic 
and hence able to bioaccumulate, and are toxic to living organisms. Sources of POPs are 
agriculture, industry and unintentionally generated by-products of incomplete reactions 
(Miniero and Iamiceli, 2008, AMAP, 2009) At present 21 substances are classified as POPs 
by the Stockholm Convention, and twelve of these constitute the legacy POPs. These 
organochlorine substances, such as polychlorinated biphenyls (PCBs), dioxins, and 
dichlorodiphenyltrichloroethane (DDT), were the first POPs to be recognized as hazardous 
to human and wildlife health and environment, and the use them are now banned or restricted 
(www.pops.int). 
Even though vast areas of the Arctic are remote from industry and human activity many 
environmental pollutants are found in these regions, due to long-range transport (Macdonal 
et al., 2000). The cold environment favors the deposition of POPs from the atmosphere, and 
the contaminants are retained in the Arctic by entering the marine food web (AMAP, 2009). 
Because arctic animals store high amounts of energy as fat in white adipose tissue (WAT), 
for periods when food availability is scarce, they have an unusually high potential of 
accumulating and storing POPs, as POPs generally are lipophilic chemicals (Gebbink et al., 
2008).  
POPs can affect the health of human and wildlife, for example by disturbing the 
development and function of the endocrine system. This can lead to developmental 
abnormalities, reduced reproductive success, alterations in the immune system, and 
metabolic disruption, such as obesity and type 2 diabetes (Colborn et al., 1993, Casals-Casas 
and Desvergne, 2011, Ruzzin et al., 2010). In polar bears effects on both on the reproductive 
and immune system have been reported (Sonne, 2010). Therefore, it is important to 
characterize, monitor, and regulate dangerous pollutants by international monitoring 
programs, such as the arctic monitoring and assessment programme (AMAP) 
(www.amap.no), and by global treaties, such as the Stockholm Convention (www.pops.int).  
As a top predator in the Arctic the polar bear accumulates high levels of POPs, and polar 
bears living in Svalbard, Hudson Bay (Canada) and East Greenland are considered to be 
especially at risk for POP exposure and associated effects (Letcher et al., 2010). The 
chemical concentration of POPs increases upwards in the food chain by the process of 
biomagnification, and apex predators, such as polar bears, are therefore exposed to higher 
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levels of persistent pollutants (Fig. 1.2.) (Hop et al., 2002, Letcher et al., 2010). Another 
factor that greatly influences the contaminant load that polar bears are subjected to, is that 
polar bears feed almost exclusively on seal blubber, and therefore accumulates unusually 
high amounts of POPs (Derocher et al., 2002, Jenssen, 2006). 
 
Figure 1.2. Bioaccumulation and biomagnification. (Figure from Olenick, 2013). 
Due to the bans and restrictions on uses of legacy POPs the levels of these chemicals 
have declined significantly in arctic biota over the last decades (Riget et al., 2010). However, 
the levels in polar bears are still high enough to exceed the toxic effect threshold, with PCBs 
as the main contributors, and this may lead to health risks (Dietz et al., 2015). Levels of 
hydroxylated and methyl sulfone metabolites of PCBs in polar bears are also over the toxic 
effect threshold, and therefore contributes to the health risk posed by PCB congeners (Sonne, 
2010, Sandala et al., 2004). Even though the use of many POPs are prohibited or restricted, 
new chemicals emerge to replace banned chemicals, or to fulfill new ranges of application. 
New chemicals, including organohalogens such as brominated flame retardants (BFRs) and 
fluorinated compounds, have been found in the arctic biota, and there are concerns about 
how they may affect the artic animals (Braune et al., 2005, Verreault et al., 2005, Bytingsvik, 
2012). It is not only the high contamination levels of distinct compounds in polar bears that 
cause concern, but also what the consequences of this combined chemical cocktail may be 
(Sonne, 2010). 
Since most POPs are lipophilic, WAT functions as storage site for these chemicals. A 
study by Gebbink et al. (2008) found that over 91 %  of the total body burden of 
organohalogens was accounted for by adipose tissue in polar bears from East Greenland. 
There is an increasing concern about how POPs can affect energy homeostasis by altering 
the function of WAT (Muellerova and Kopecky, 2007). Also, when polar bears perform their 
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seasonal fasting, stored fat is utilized for energy and this leads to an increased release of 
POPs from the WAT into the blood stream. This subsequently leads to an increased 
concentration of POPs in other organs and tissues, which can lead to hazardous health effects 
(La Merrill et al., 2013).  
1.2 WHITE ADIPOSE TISSUE 
WAT is found all over the body, as subcutaneous fat, under the skin, or as visceral fat, 
surrounding the organs (Ibrahim, 2010).  For a long time WAT was considered as a passive 
organ that only functioned as storage for energy. This view has changed, and WAT is now 
recognized as a highly active metabolic and endocrine organ, which responds to hormonal 
signals, but also secretes signaling factors, such as leptin (Kershaw and Flier, 2004). The 
secreted factors are known to play a central role in regulating energy expenditure, satiety, 
and insulin sensitivity; and dysfunction of the regulation of the secreted factors can lead to 
metabolic diseases, such as diabetes, and inflammatory responses (Galic et al., 2010). 
Adipocytes, or fat cells, are the main cell type in WAT, but the tissue also contains stromal 
vascular cells, which include endothelial cells, fibroblasts, immune cells, committed 
preadipocytes, and stem cells (Katz, 2002). The quantity of WAT in the body varies with 
energy intake and depletion. Previously WAT was believed to have a fixed number of 
adipocytes which varied in size, but now it is established that that the change in mass is a 
result of change in both size and numbers of adipocytes (Prins and O'Rahilly, 1997).  
1.3 FORMATION OF FAT CELLS BY ADIPOCYTE DIFFERENTIATION 
The increase in number of adipocytes during expansion of WAT, is due to the 
differentiation of preadipocytes into mature adipocytes, known as adipogenesis (Gregoire, 
2001). During adipogenesis sequential changes in the expression of specific adipocyte genes 
occur, which leads to changes in cell appearance and function, as it starts to accumulate 
triglycerides in large vacuoles (Niemelä et al., 2008, Fan et al., 1983).  
Adipocyte differentiation has been extensively studied for the past 20 years using cell 
culture models of various preadipocyte cell lines, such as 3T3-L1, and primary cultures of 
mesenchymal stem cells (MSCs), from sources such as humans, rats, rabbits and pigs 
(Gregoire et al., 1998). For MSCs to be able to differentiate into mature adipocytes the cells 
must first commit to the preadipocyte lineage, meaning that the cells are restricted to 
differentiate into adipocytes, succeeded by terminal differentiation, which is induced by 
adipogenic stimuli (Cristancho and Lazar, 2011). The differentiation from preadipocytes into 
mature adipocytes is a complex process which involves changes in the expression of over 
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2000 genes (Guo and Liao, 2000). Understanding the molecular events that takes place 
during this process is a major task and there are still numerous gaps in our knowledge, 
especially concerning the early stages of adipogenic commitment and differentiation 
(Gregoire, 2001). The process, and some of the key transcription factors (TFs) (Fig. 1.3.) 
will be briefly explained.  
 
Figure 1.3. Regulation of adipogenesis by transcription factors (TFs). Adipogenesis is regulated 
through two waves of TFs (figure modified from Fajas, 1998).  
1.3.1 Induction of adipocyte differentiation 
The mechanisms by which MSCs, in vitro and in vivo, commits to the preadipocyte 
lineage is still a poorly understood process (Cawthorn et al., 2012), and will not be discussed 
here. Cultured preadipocytes have to enter growth arrest before adipocyte differentiation is 
possible. This is normally achieved through contact inhibition, by culturing the cells until 
confluence is reached, which leads to growth arrest. However, confluence in itself is not 
required for adipocyte differentiation, as it is possible to enter cells into growth arrest by 
using certain serum-free media. Both peroxisome proliferator-activated receptor gamma 
(PPARγ) and CCAAT-enhancer-binding protein alpha (C/EBPα) is found to play a role in 
inducing growth arrest (Gregoire et al., 1998). 
After growth arrest is achieved, adipogenic differentiation can be initiated, if the cells 
receive appropriate adipogenic stimuli. Through studies using cell models, it has become 
clear that adipogenesis is a process that occurs through the activation of two waves of 
transcription factors (TFs). During in vitro studies the first wave is induced directly by an 
adipogenic induction medium (AIM) (Lefterova et al., 2014). The AIM may contain several 
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adipogenic stimulating compounds, such as dexamethasone (DEX), 3-isobutyl-1-
methylxanthine (IBMX), indomethacin (INDO) and insulin, which induces different TFs. 
DEX induces the glucocorticoid receptor (GR) and C/EBPδ, and inhibits preadipocyte factor 
1 (PREF-1), an inhibitor of adipocyte differentiation (Wu et al., 1996, Smas et al., 1999). 
IBMX elevates the cyclic AMP (cAMP) levels in the cells, which stimulates the cAMP 
response element-binding protein (CREB). CREB is considered to be a primary regulator of 
adipogenesis and promote the transcription of several adipocyte-specific genes, such as 
C/EBPβ (Reusch et al., 2000, Niehof et al., 1997). INDO increases the expression of both 
PPARγ and C/EBPβ (Lehmann et al., 1997, Styner et al., 2010). 
The first wave TFs in turn activate TFs of the second wave, such as PPARγ and C/EBPα. 
These two TFs have binding sites at most genes associated with adipogenesis, and have been 
shown to crosstalk with each other (Siersbaek et al., 2010). The molecular basis by which 
the two TFs cooperate to regulate adipogenesis is still not known, but many adipocyte 
specific genes have binding sites for both C/EBP proteins and PPARγ (Rosen et al., 2000). 
Binding of the TFs leads to the activation and regulation of the adipocyte specific genes 
needed for the terminal differentiation of preadipocytes, such as fatty acid-binding protein 4 
(FABP4) (Lefterova et al., 2014). Insulin activates the insulin-like growth factor 1 (IGF1) 
receptor and induces several downstream transduction pathways, such as the activation of 
adipocyte determination and differentiation factor 1 (ADD1) (Mur et al., 2003, Niemelä et 
al., 2008). The mechanisms by which ADD1 induces adipogenic differentiation remains 
unknown, but ADD1 is known to promote adipocyte differentiation and gene expression 
linked to triglyceride synthesis (Kim and Spiegelman, 1996, Rosen et al., 2000) 
1.3.2 The CCAAT-enhancer-binding proteins 
Three of six members of the C/EBP family are known to play a part during induction and 
regulation of adipocyte differentiation. These are the TFs C/EBPα, C/EBPβ and C/EBPδ 
(Mandrup and Lane, 1997). One of the main functions of C/EBPβ and C/EBPδ during 
adipogenesis is to induce the expression of C/EBPα and PPARγ (Rosen and MacDougald, 
2006). During the early phase of adipogenic differentiation there are expressed high levels 
of C/EBPβ and C/EBPδ, induced by IBMX and DEX. During the terminal phase of 
differentiation the levels of these TFs diminish, while the level of C/EBPα increases (Yeh et 
al., 1995). Slightly after the increase in expression of C/EBPα most of the adipocyte specific 
genes are being activated (Rosen et al., 2000). 
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The C/EBPs are absolutely required to accomplish adipogenic differentiation, but the 
presence of PPARγ is needed for these TFs to function efficiently (Lin and Lane, 1992, 
Rosen and MacDougald, 2006). For instance, C/EBPβ cannot induce the expression of 
C/EBPα in the absence of PPARγ (Zuo et al., 2006). C/EBPα cooperates with PPARγ 
towards terminal differentiation, and also sustains a high level of PPARγ in the mature 
adipocyte through a feed-forward loop (Fajas et al., 1998). 
1.3.3 Peroxisome proliferator-activated receptor gamma  
Rosen et al. (1999) showed that PPARγ is required for adipogenic differentiation, both 
in vitro and in vivo, and today PPARγ is considered as the master regulator of adipogenesis. 
The PPARs are TFs that belong to the nuclear receptor (NR) superfamily (Mangelsdorf 
et al., 1995). The PPARs include PPARα, PPARβ and PPARγ, and they function as lipid 
sensors that adapt gene expression to regulate lipid metabolism. Fatty acids and eicosanoids 
are examples of natural PPAR ligands, but PPARs also bind to a variety of xenobiotics such 
as plasticizers, dioxins and pesticides (Berger and Wagner, 2002, Casals-Casas and 
Desvergne, 2011). In addition, synthetic PPARγ ligands, such as rosiglitazone (ROSI), are 
used in medicine for their antidiabetic effects (Kersten et al., 2000). 
PPARα is mainly expressed in tissues with a high rate of fatty acid catabolism, such as 
muscles, brown adipose tissue and liver, where it is involved in fatty acid oxidation, and 
control of lipoprotein metabolism and inflammation limitation. PPARβ has been detected in 
all tested tissues, and have an overlapping role with PPARα in addition to play a part in cell 
differentiation and survival. PPARγ is predominately expressed in adipose tissue, where it 
is involved in controlling adipogenesis, lipid storage, and insulin sensitivity (Casals-Casas 
and Desvergne, 2011). Due to the major role of PPARγ in adipogenesis we will focus on the 
function of this isoform. 
All PPARs must form heterodimers with retinoid X receptor (RXR), another nuclear 
receptor, before activation of their target genes is possible (Fig. 1.4.) (Wagner et al., 2010).  
Ligand-bound PPARγ alters its conformation and forms a heterodimer with RXR, which has 
9-cis retinoic acid as its natural ligand. Nuclear coactivators binds to the PPARγ-RXR 
heterodimer, and the transcriptional machinery binds to specific DNA sequence elements, 
designated PPAR response element (PPRE), and controls the expression of numerous target 
genes, such as lipoprotein lipase (LPL), fatty acid-binding protein 4 (FABP4), and leptin 
(LEP) (Cho et al., 2008, Tontonoz et al., 1994, Hollenberg et al., 1997). 
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Figure 1.4. Mode of action of PPARy. Ligand bound PPARγ forms a heterodimer with RXR, which 
translocate into the nucleus and binds to the PPAR response element (PPRE) and controls expression 
of numerous target genes (Figure modified from Wagner et al., 2010)  
PPARγ target genes are involved in regulating processes such as initiating growth arrest, 
triglyceride synthesis, accumulation of fat in cells and insulin sensitivity (Tontonoz and 
Spiegelman, 2008). 
1.3.4 Fatty acid-binding protein 4 
The FABPs belong to the lipid binding protein superfamily, and 9 different FABPs are 
identified in mammals. The primary role of all FABPs is to regulate fatty acid uptake and 
metabolism, and facilitate intracellular transport of fatty acids. The different FABPs are 
tissue specific, and adipocytes express high levels of FABP4 (Storch and Thumser, 2010). 
FABP4 bind various hydrophobic ligands, and many of them are of the same character as 
the ligands that bind to PPARγ. FABP4 increases the aqueous solubility of its bound ligands, 
and aids in their intracellular transportation (Chmurzynska, 2006). One route of 
transportation is when FABP4 delivers ligands from the cytosol into the nucleus to PPARγ, 
and thereby enhance the activity of this important transcription factor (Ayers et al., 2007). 
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1.3.5 Leptin 
Leptin is a protein hormone that is expressed in, and secreted by, mature adipocytes and 
has been extensively studied due to its direct link to obesity (Auwerx and Staels, 1998). The 
hormone has been associated with regulating food intake, energy expenditure, and whole-
body energy balance in mammals, such as rodents and humans (Houseknecht et al., 1998). 
Secreted leptin enters the circulation system and interacts with the central nervous system 
by binding to the leptin receptor, for example in the hypothalamus, which leads to a cascade 
of biological responses (Campfield et al., 1996, Tartaglia et al., 1995). 
The secretion of leptin is positively correlated to the adipose tissue mass, but the 
expression is also regulated by factors such as nutritional status and signaling molecules, 
such as insulin, and estrogens, which elevates the levels of leptin (Kershaw and Flier, 2004). 
TFs, such as C/EBPα and PPARγ, are known to control the transcriptional regulation of 
leptin (Houseknecht et al., 1998). 
1.4 ADIPOSE TISSUE-DERIVED STEM CELLS 
Stem cells are divided into two types; embryonic stem cells, and adult stem cells, which 
are known as mesenchymal stem cells (MSCs). MSCs are stromal cells that are able to self-
renew and to differentiate into different cell types, such as osteoblasts, chondrocytes, or 
adipocytes (Ding et al., 2011, Minguell et al., 2001). Most of the studies conducted on MSCs 
have used stem cells isolated from bone marrow (BMSC). However, isolating cells from 
bone marrow can result in pain and risk of infections in the donor, as well as in yielding low 
cell numbers upon harvest. Recent advances in stem cell research have led to the discovery 
that MSCs can be isolated from a variety of tissues, such as adipose tissue (Zuk et al., 2002, 
Ding et al., 2011).  
The first report on the isolation of MSCs from adipose tissue came in 2001. Human 
adipose tissue was obtained by liposuction, and the stromal vascular fraction (SVF) was 
isolated. The majority of cells in the SVF were of mesenchymal origin with low levels of 
other cell types, such as endothelial cells. The cells could be cultured over time with stable 
population doublings and low levels of senescence, and were able to differentiate in vitro 
into adipogenic, chondrogenic, myogenic and osteogenic cells, when introduced to the 
appropriate induction factors (Zuk et al., 2001). Since, the interest in adipose tissue-derived 
stem cells (ASCs) has increased, especially in the field of tissue engineering (Bunnell et al., 
2008). ASCs have some clear advantages over BMSCs, as adipose tissue is abundant and 
readily accessible, and it is easy to harvest samples from a donor with minor discomfort 
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(Bunnell et al., 2008, Nakagami et al., 2006). Also, the cell number yields are higher, as the 
adipose tissue is a rich source of stem cells, and they can be more heavily expanded and 
maintain the ability for differentiation at higher passages (Zhu et al., 2008, Zachar et al., 
2011). 
As cultured ASCs are primary cultures and not established cell lines, there are some 
aspects to keep in mind when working with such cultures, such as from where, and from 
whom the cells are obtained. In rats, ASCs isolated from subcutaneous fat had a higher 
differentiation capacity than ASCs isolated from visceral fat (Gregoire et al., 1990). Cells 
isolated from different donors have been shown to display varying degree of differentiation 
ability (Sen et al., 2001). One of the reasons for this may be that ASCs from older donors 
have a reduced ability to replicate and differentiate (Choudhery et al., 2014). Also, cell 
density and time in culture can affect cell characteristics such as morphology, differentiation 
ability and gene expression patterns (Neuhuber et al., 2008). 
1.5 ENDOCRINE DISRUPTING CHEMICALS 
Endocrine disrupting chemicals (EDCs) are exogenous chemicals, such as POPs, which 
can disturb the function of the endocrine system, by affecting various hormone systems, and 
consequently affect health aspects and reproduction in an organism, or its offspring (Damstra 
et al., 2002, Casals-Casas and Desvergne, 2011, UNEP/WHO, 2013). Several EDCs have 
been linked to metabolic disruption, leading to obesity, metabolic syndrome, and type 2 
diabetes (Casals-Casas and Desvergne, 2011). EDCs which can influence adipogenesis and 
cause obesity are often referred to as environmental obesogens (Grun and Blumberg, 2006). 
Hormones regulate the endocrine system via transcription factors (TFs), including 
membrane bound receptors, which respond to peptide hormones, or nuclear receptors (NRs). 
Small lipophilic compounds, such as steroid hormones as well as other endogenous 
compounds and xenobiotics, including POPs, activate NRs (Casals-Casas and Desvergne, 
2011). 
EDCs are able to interact with one or more NRs, such as pregnane X receptors (PXR) 
and the peroxisome proliferator-activated receptor (PPAR) family, and in turn influence the 
expression of genes regulated by these TFs (Lille-Langoy et al., 2015, Grun and Blumberg, 
2009). PCBs, dioxins, organotins, fluorinated compounds, phthalates, and bisphenol A 
(BPA) have been categorized as environmental obesogens, by causing metabolic disruption 
through interactions with several NRs, such as PPARγ or the glucocorticoid receptor (GR) 
(Casals-Casas and Desvergne, 2011). In this study the effect of the phthalate mono(2-
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ethylhexyl)phthalate (MEHP) and bisphenol A (BPA) on adipocyte differentiation of polar 
bear adipose tissue-derived stem cells (pbASCs) have been investigated. 
1.5.1 Mono(2-ethylhexyl)phthalate 
Phatalates are a group of industrial chemicals which are commonly used as plasticizers 
to soften polymer products, mainly polyvinyl chloride (PVC) products. The most widely 
used phatalate is bis(2-ethylhexyl)phthalate (DEHP). DEHP is found in a range of products, 
such as flooring, cables, toys and clothes (ECHA, 2009). Upon digestion DEHP is 
metabolized into MEHP. MEHP has been shown to activate PPARγ, and thereby contributes 
to adipocyte differentiation by activating this NR pathway (Feige et al., 2006, Hurst and 
Waxman, 2003, Taxvig et al., 2012). 
1.5.2 Bisphenol A 
BPA is also an industrial chemical used in plastics. It is used to make polycarbonate, a 
hard, clear plastic. Polycarbonate is used in many consumer products, such as bottles and 
food containers (fda.gov, 2014). Previous studies have found that BPA induce adipocyte 
differentiation in 3T3-L1 cells (Taxvig et al., 2012, Masuno et al., 2002, Bastos Sales et al., 
2013), but by a PPARγ independent mechanism (Chamorro-Garcia et al., 2012). Several 
mechanisms have been proposed for the induction of BPA on adipogenesis, such as 
activation of the glucocorticoid receptor (GR), or through the phosphatidylinositol 3-kinese 
pathway (Sargis et al., 2010, Masuno et al., 2005). Interestingly, findings have indicated that 
BPA does not induce adipocyte differentiation in BMSCs, from human or mouse (Chamorro-
Garcia et al., 2012) 
1.6 BACKGROUD OF THE STUDY 
This study is a part of the project “Contaminant effects on energetics”  in the Fram Centre 
Hazardous Substances – program. The project aims to investigate the impact of contaminant 
exposure on energy homeostasis in arctic wildlife, such as polar bears. One of the projects’ 
main focuse is to investigate the effects of contaminants on endpoints that are stressed by 
climate change effects, such as energy metabolism, and the project hypothesizes that 
“contaminant exposure in arctic wildlife may affect their energy homeostasis and thus 
decrease their ability to respond to climate change”. As the polar bear endures a 
physiological stressful seasonal fasting period, it is important that polar bears possess an 
optimal control of their metabolism. Exposure to contaminants may interfere with regulation 
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of metabolism by disturbing the function of nuclear receptors (NRs), such as the peroxisome 
proliferator-activated receptor gamma (PPARγ) (Grun and Blumberg, 2007). 
As a part of the “Contaminant effects on energetics” project the effect of contaminant 
mixtures, consisting of contaminants at the composition and concentration found in polar 
bear adipose tissue, on adipogenesis in a cell line of preadipocytes derived from mouse (3T3-
L1 cells) have been studied (Routti et al, unpublished). But it is possible that contaminant 
exposure may affect polar bears differently. A reason for this is because polar bears exhibit 
molecular adaptations in genes associated with bioenergetics, due to adaptation to the arctic 
environment (Welch et al., 2014). Among other factors the polar bear endure cold 
temperatures, feed on a marine lipid rich diet, store high amounts of energy as fat and endure 
a seasonal fasting period.  Also, it has been found that the ligand binding domain of PPARγ 
differs between mouse and polar bear (Routti et al, unpublished). 
This study will focus on developing methods for using polar bear adipose-tissue derived 
stem cells (pbASCs) to gain more knowledge on how contaminant exposure may affect 
energy homeostasis in polar bears.  
1.7 AIMS 
The main goal of this thesis was to develop an in vitro method for studying effects of 
environmental contaminants on adipogenesis in polar bears using pbASCs. This was 
addressed through the following sub-goals: 
1. Establish a method for successfully maintaining and propagate pbASCs in culture. 
2. Investigate the pbASCs’ capability of adipogenic differentiation, when induced by 
adipogenic stimuli. 
3. Establish conditions which allowed for low and high level of adipogenic 
differentiation 
4. Assess the effect of known endocrine disrupting chemicals (EDCs) on adipogenic 
differentiation in polar bears. 
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2 MATERIALS 
2.1 GENERAL CHEMICALS AND REAGENTS 
Table 2.1. General chemicals and reagents 
Chemical Cat. No. Supplier 
10X loading buffer 9157 TaKaRa 
2-Log DNA Ladder (0.1-10.0 kb) N3200L New England Biolabs 
3-Isobutyl-1-methylxanthine (IBMX)  I7018 Sigma-Aldrich 
Agar-Agar 1.01614.1000 Merck 
Agarose (SeaKem® LE) 50004 Lonza 
Ampicillin sodium salt A9518 Sigma-Aldrich 
β-mercaptoethanol M6250 Aldrich 
Bisphenol A (BPA) 239658 Sigma-Aldrich 
Boric Acid 1.00165.1000 Merck 
Bovine Serum Albumin (BSA) (0.1%)  TaKaRa 
Dexamethasone (DEX) D4902 Sigma-Aldrich 
Dimethyl sulphoxide (DMSO) D2650 Sigma-Aldrich 
dNTPs (dATP, dCTP, dGTP, dTTP) 201912 Qiagen 
Ethanol (EtOH) 32221 Sigma-Aldrich 
Ethidium bromide (EtBr) E1510 Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) 1.08418.10000 Merck 
Fetal bovine serum (FBS) F7524 Sigma-Aldrich 
Formalin solution, neutral buffered, 10 %  HT501128 Sigma-Aldrich 
Formamide F9037 Sigma-Aldrich 
Gentamicin solution G1397 Sigma-Aldrich 
Hanks balanced salt solution H6648 Sigma-Aldrich 
Indomethacin I7378 Sigma-Aldrich 
Insulin I2643 Sigma-Aldrich 
Isopropanol E41333 Kemetyl 
L-Glutamine G7513 Sigma-Aldrich 
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Minimum essential medium eagle, alpha 
modification (α-MEM) M4526 Sigma-Aldrich 
Oil Red O O0625 Sigma-Aldrich 
Penicillin-Streptomyecin solution P4333 Sigma-Aldrich 
Mono-2-etylhexyl ester phthalate 
(MEHP) CDS010608 Sigma-Aldrich 
Potassium chloride P9541 Sigma-Aldrich 
Potassium dihydrogen phosphate 4873.1 Merck 
Rosiglitazone R2408 Sigma-Aldrich 
SOC Outgrowth Medium B9020S BioLabs Inc. 
Sodium chloride 1.06404.1000 Merck 
Sodium phosphate dibasic dihydrate 30435 Sigma-Aldrich 
Trizma® base T1503 Sigma-Aldrich 
Tryphan blue solution 93595 BioWhittakerTM 
Trypsin + EDTA solution (0.25 %) T4049 Sigma-Aldrich 
Tryptone 1.11931.1000 Merck 
Yeast Extract 92144 Fluka 
 
2.2 GENERAL BUFFERS AND SOLUTIONS 
 
Table 2.2. 10X Phosphate buffered saline 
(PBS), pH 7.4 
Compound Concentration 
NaCl 80 g/L 
KCl 2 g/L 
Na2HPO4 
KH2PO4 
14.4 g/L 
2.4 g/L 
Table 2.3. 5X Tris-borate-EDTA (TBE) 
buffer, pH 8.3 
Compound Concentration 
Tris base 54 g/L 
Boric acid 27.5 g/L 
EDTA 4.65 g/L 
 
Table 2.4. Oil Red O Stock Solution 
Compound Concentration 
Oil Red O 3.5 mg/mL 
Isopropanol 100 % 
-Stir 2 hours, filter (0.2 µm), store protected from light at RT 
- Work solution:  mix two parts stock solution and one part 
destilled water, stir 20 min, filter (0.2 µm) 
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2.3 GROWTH MEDIA  
2.3.1 Growth media used for pbASCs 
Table 2.5. Composition of growth medium for pbASCs 
Compound Concentration 
Minimum essential medium eagle, 
alpha modification (α-MEM) 1X 
Fetal bovine serum (FBS) 10% v/v 
Penicillin-Streptomyecin 100 U/mL 
L-glutamine 4 mM 
Gentamicin  50 µg/mL 
-Freezing medium: 30% v/v FBS, 10% v/v DMSO 
 
2.3.2 Bacterial growth media
Table 2.6. Lysogeny broth (LB) medium 
Compound Concentration 
Tryptone 10 g/L 
Yeast extract 5 g/L 
NaCl 10 g/L 
-LB-Ampicillin medium: 0.1 mg/mL 
Ampicillin added  
Table 2.7. LB-ampicillin agar plates 
Compound Concentration 
LB medium  
(Table 2.5.) 
Agar 15 g/L 
Ampicillin 0.1 mg/mL 
  
 
2.4 PLASMIDS AND PRIMERS 
Table 2.8. Previously linearized pSC-A vectors containing gene fragment insert used for Q-
PCR standard curve 
Gene fragment insert Origin 
Pb_PPARy Roger Lille-Langøy, University of Bergen, 
Norway Pb_FABP4 
Pb_PPIA 
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Table 2.9. Primers used for amplification of fragments of selected polar bear genes 
Name Sequence (5'-3') 
Pb_PPARy_fwd CACAATGGCATCAGGTTTGG 
Pb_PPARy_rev GGGGGTGATGTGGTGTTTGAAC 
Pb_FABP4_fwd GAAGTAGGAGTGGGCTTTGC 
Pb_FABP4_rev AGGACACCTCCATCTAAGGTT 
Pb_LEP fwd TGCATTCCAGAAATGTGGTC 
Pb_LEP rev ACCACCTCCGTGGAGTACAG 
Pb_YWHAZ_fwd ACTTTTGGTACATTGTGGCTTCAC 
Pb_YWHAZ_rev CCGCCAGGACAAACCAATAT 
Pb_PPIA_fwd GTCTCCTTTGAGCTGTTTGC 
Pb_PPIA_rev AGTCTTGGCAGTGCAGATGA 
 
Table 2.10. Primers specific for the pSC-A vector 
Name Sequence (5'-3') 
M13-20 ACTGGCCGTCGTTTTAC 
T3 AATTAACCCTCACTAAAGGGAA 
2.5 KITS 
Table 2.11. Kits 
Name Cat. No Supplier 
AurumTM Total RNA Mini Kit  732-6820 Bio-Rad 
MicroElute® Gel Extraction Kit D6294 Omega bio-tek 
iScriptTM cDNA synthesis kit  170-8891 Bio-Rad 
StrataClone PCR Cloning Kit 240205 Agilent Technologies 
E.Z.N.A® Plasmid DNA Mini Kit 1 D6942 Omega bio-tek 
GenEluteTM PCR Clean-Up Kit  NA1020 Sigma-Aldrich 
iQ™ SYBR® Green Supermix 170-8882 Bio-Rad 
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2.6  APPARATUS AND SOFTWARE 
Table 2.12. Apparatus and software 
Application Name Manufacturer 
Centrifugation Himac CT15RE  VWR 
 Galaxy ministar VWR 
 Heraeus Multifuge X3R Thermo Scientific 
 Avanti J-26 XP Bekman Coulter 
Electrophoresis PowerPac HC Bio-Rad 
Heating Thermomixer compact Eppendorf 
 VorTemp™ 56EVC Labnet 
 AMW 232 Whirlpool 
 GD100 Grant 
Imaging Gel Doc™ EZ Imager Bio-Rad 
 + Image lab 3.0  
Incubation Galaxy 170 R New Brunswick 
 Infors HT Mulititron Standard VWR 
 INCU-Line VWR 
Microscopy DMIL LED LEICA Microsystems 
 SMZ-645 Nikon 
Mixing Magnetic stirrer, VS-C7 VWR 
 Lab Dancer IKA® 
 Vortex genie 2  Scientific Industries 
pH measurement pHM210 Standard pH Meter MeterLab® 
Plate reading EnSpire™ 2300 Multilabel reader PerkinElmer 
 + EnSpire manager v 4.0.3006.25  
Shaking HS501 Digital IKA®-Werke 
Sonication 
4710 Series Ultrasonic 
Homogenizer 
Cole-Pharmer Instrument 
Co. 
Spectrophotometry NanoDrop® ND-1000 Saveen Werner 
 + NanoDrop 1000 3.81  
Sterile 
environment Scanlaf Mars LaboGene 
Thermocycling DOPPIO VWR 
 LightCycler® 480 Roche 
 + LightCycler® 480 software  
Water supply Advantage A10 Millipore 
Weighing SI-64 Denver Instrument 
 EK-300i A&D 
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2.7 ENZYMES AND CORRESPONDING BUFFERS 
Table 2.13. Enzymes and corresponding buffers 
Compound Concentration Cat. No Supplier 
Polymerase    
DreamTaq DNA Polymerase 5 U/µL EP0702 Thermo Scientific 
+ DreamTaq Green Buffer 10X B71  
Restriction endonucleases    
Not I 10 U/µL 1166A TaKaRa 
+ Buffer H 10X   
Xba I 15 U/µL 1093A TaKaRa 
+ Buffer M 10X   
Sequencing    
BigDye® Terminator v3.1  4337455 
Applied 
Biosystems 
+ BigDye sequencing Buffer    
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3 METHODS 
3.1 COLLECTION OF POLAR BEAR ADIPOSE TISSUE SAMPLES AND 
SUBSEQUENT ISOLATION OF ADIPOSE TISSUE-DERIVED STEM CELLS 
Adipose tissue samples from a 10 year old male polar bear were collected by the 
Norwegian Polar Institute, as a part of the BearEnergy project, at Svalbard in September 
2012. The polar bears were immobilized by remote injection of a dart containing the drug 
Zoletil ® 100 (Virbac, France), fired from a helicopter. Adipose tissue samples were 
collected using an 8 mm sterile biopsy punch. Samples were transferred in phosphate 
buffered saline (PBS) and kept at room temperature (RT). The stromal vascular fraction 
(SVF), containing the polar bear adipose tissue-derived stem cells (pbASCs), was isolated 
from tissue samples at Alborg University by Trine Fink as previously described (Fink et al., 
2011), within 48 hours of harvest. Cells in passage two were frozen in aliquots of 
approximately 1 x 106 cells, transported to and stored in the vapor phase of liquid nitrogen 
at the University of Bergen. 
3.2 HANDLING POLAR BEAR ADIPOSE TISSUE-DERIVED STEM CELLS 
(pbASCs)  
3.2.1 Cryopreservation and thawing  
Cryopreservation is widely used to preserve cells long term, and all pbASCs used have 
been cryogenically frozen. ASCs can be frozen and thawed with minimal loss of viability, 
and without loss of differentiation potential (Minonzio et al., 2014).  However, thawing is a 
stressful process for the cells, and needs to be done quickly to ensure that the cells remain 
viable and able to recover afterwards.  
When cultured pbASCs needed to be cryogenically frozen for storage, the cells were 
distributed in aliquots of approximately 1 x 106 cells in cold freezing medium, containing 10 
% DMSO (Table 2.5.), frozen at -80 °C for 24 hours and transferred to the vapor phase of 
nitrogen for long term storage. 
PbASCs were thawed in lukewarm water bath and resuspended in 5 mL growth medium 
(GM, Table 2.5.). The freezing medium was removed by centrifugation (500 x g for 5 
minutes), before cells were resuspended in fresh GM and seeded at a density of 3000 
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cells/cm2 in 300 cm3 cell culture flasks1. Cells were cultivated at 37 °C and 5 % CO2, and 
GM was replaced twice a week during expansion.  
3.2.2 Subculturing 
During culturing the cells were observed visually, by using an inverted microscope, to 
monitor for changes in appearance, and to ensure that no contamination by bacteria etc., had 
occurred.  
At approximately 70 % confluency pbASCs were subcultured (i.e. passaged) using the 
proteolytic enzyme trypsin to dissociate the adherent cells from the culture vessel. The cells 
were washed twice with 1 x PBS, pH 7.4, covered with 0.125 % Trypsin/0.1 % EDTA (0.5 
mL per 10 cm3) and incubated at 37 °C for 3 minutes. Dissociation was confirmed under the 
microscope. Trypsinization was stopped by addition of growth medium. To remove trypsin 
from the medium, the cell suspension was centrifuged (500 x g, 5 minutes), and the pellet 
resuspended in growth medium (Table 2.5.). Cell density was determined (3.2.3) and cells 
were reseeded as previously described. 
In addition, the effect of reaching confluence during subculturing on contact inhibition 
was investigated.  PbASCs, in passage 5, which had not been above 70 % confluent, and 
cells, in passage 7, who had been confluent during subculturing were cultured to confluency 
in 6-well plates and maintained in culture for 37 days. The experiment was executed once, 
without parallels. 
PbASCs were generally subcultured when approximately 70 % confluence was reached, 
but we wanted to see if reaching 100 % confluence before subculturing would have any 
effect on contact inhibition. Cells, in passage 5, that had never been above 70 % confluent, 
and cells, in passage 7, that had been 100 % confluent during subculturing were cultured to 
100 % confluence in 6-well plates and maintained in that culture for 37 days. 
3.2.3 Determining cell density and viability 
Cell density was determined using a haemocytometer and viability evaluated by the 
trypan blue exclusion test. The haemocytometer determines cell density by counting the 
number of cells in a specific volume of fluid. The trypan blue stain passes through the cell 
                                                 
1 The decision to seed pbASCs at a density of 3000 cells/cm2 in 300 cm3 cell culture flasks as the standard 
method was based on experience acquired during the early stages of this study. Initially, 10 cm culture dishes 
and a seeding density of 5000 cells/cm2 were used. 
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membrane of dead cells, but is excluded from live cells. Using phase contrast microscopy, 
dead cells appear blue, while living cells appear colorless.  
Equal volumes of cell suspension and 0.4 % trypan blue stain was mixed. Cells in the 
four corner squares of the haemocytometer were counted, and the concentration (cells/mL) 
was calculated by multiplying the average number of cells per square with 2 (dilution factor) 
and 104 (volume conversion factor). Percent viability was calculated by dividing viable cells 
on the total number of cells, multiplied by 100. 
3.3 ADIPOGENIC DIFFERENTIATION 
3.3.1 General adipogenic differentiation procedure and method establishment 
As a starting point for this study we took basis in an adipogenic differentiation method 
previously used for both human and brown bear (Ursus arctos) ASCs (Fink et al., 2008, Fink 
et al., 2011). The following principles for adipogenic differentiation of pbASCs was used 
during experiments: Cells in passage 5 were seeded in 6-well or 12-well cell culture plates 
at a density of 20,000 cells/cm3 in growth medium (Table 2.5) and cultivated to 100 % 
confluency, designated as day -2. After two days (day 0) adipogenic differentiation was 
initiated by using an adipogenic induction medium (AIM). The AIM was changed twice a 
week, as illustrated below (Fig. 3.1.) On day 14 cells were either fixed for quantification of 
lipid content (3.4), or RNA was extracted for subsequent analysis of transcript levels (3.5.1).  
 
Figure 3.1. Differentiation protocol for pbASCs. 
Because adipose tissue-derived stem cells from polar bears have not previously been 
studied, to our knowledge, suitable conditions for adipogenic differentiation needed to be 
established (4.2.1). To establish the duration of the induction period needed for the cells to 
go through adipogenic differentiation, cells were initially grown in AIM for 1, 2 or 3 weeks. 
Seven different AIMs, which consisted of GM (Table 2.5.) supplemented with various 
concentrations of the adipogenic inducers 3-isobutyl-1-methylxanthine (IBMX), 
indomethacin (INDO), dexamethasone (DEX), rosiglitazone (ROSI) and insulin (Table 3.1.) 
were tested to find the AIM most suitable for the pbASCs. Non-induced control cells were 
maintained in basal medium (BM) (Table 3.1.)  The experiment was conducted once, in 
exposures in triplicates. 
Day -2: Cells are 
100 % confluent 
Day 0  Day 14: Fixation  
or RNA extraction 
Day 3 Day 7 Day 10 
Growth medium  Adipogenic induction medium 
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Also, the effect of ROSI on adipogenic conversion was evaluated by inducing cells in 
MDI+ROSI, or MDI+ 0.1 % DMSO (4.2.2). 
Part of the experiments were repeated in both 6- and 12-well plates, to see if similar 
results were obtained with different well sizes, and which well size would be most suitable 
to use in experiments, both for quantification of lipid content and measuring transcript levels 
(Appendix A). 
Table 3.1. Concentration of adipogenic inducers in adipogenic induction media (AIMs). 
 Concentration of components in AIMs 
AIM IBMX (μM) 
Insulin 
(µg/mL) 
INDO 
(μM) 
DEX 
(μM) 
ROSI 
(μM) 
MII200 450 1 200   
MDII200 450 1 200 0.1  
MDII200R 450 1 200 0.1 1 
MII50 450 1 50   
MDII50 450 1 50 0.1  
MDII50R 450 1 50 0.1 1 
MDI+ROSI 450 1  0.1 1 
BM  1    
 
3.3.2 Test of adipogenic potential of known EDCs in exposure experiments 
To test the adipogenic potential of selected EDCs cells were seeded in 12-well plates, 
and the general procedure (3.3.1) was followed. On day 0 the growth medium was changed 
to basal medium (BM) or MDI (Table 3.2.), supplemented with DMSO, ROSI, or test 
chemicals, at concentrations denoted in Table 3.3. BM + DMSO was used as an 
undifferentiated control, while MDI + DMSO were used as a differentiated control with a 
low level of differentiation, which allowed for the discrimination of the effects of the test 
chemicals. Cells subjected to quantification of lipid content by Oil Red O (ORO) staining 
were seeded in triplicates, while cells used for real time Q-PCR were seeded in duplicates. 
Experiments were repeated twice.  
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Table 3.2. Concentration of adipogenic inducers in media used during exposure experiments 
  Adipogenic inducers 
Media IBMX (μM) Insulin (µg/mL) DEX (μM) 
BM   1  
MDI 450 1 0.1 
 
Table 3.3. Concentration of solvent and test chemicals used in exposure experiments 
Chemical Concentration 
DMSO 0.10 % 
Rosiglitazone (ROSI) 1 µM 
Mono(2-ethylhexyl)phthalate 
(MEHP) 50 µM or 10 µM 
Bisphenol A (BPA) 50 µM or 10 µM 
 
3.4 QUANTIFICATION OF LIPID CONTENT BY OIL RED O STAINING 
During adipogenesis lipid droplets accumulate in the cell (Gregoire et al., 1998). These 
droplets can be visualized using Oil Red O (ORO), a lipid soluble dye. By extracting ORO 
from the cells, adipogenic differentiation, measured by increase in lipid content, can be 
quantified by spectrophotometry, as described by Ramirez-Zacarias et al. (1992). 
pbASCs were gently washed twice in 1X PBS (Table 2.2.) and fixed in 10 % formalin at 
4° for minimum 1 hour while protected from light. Excess formalin was removed, and the 
cells washed twice with 1X PBS before staining. The cells were covered with freshly 
prepared ORO working solution (Table 2.4.), and incubated for 15 minutes at room 
temperature before excess ORO was removed. The cells were washed repeatedly with 
deionized water until the washing solution was clear. Following washing, excess water was 
removed, and plates were left to dry. ORO was eluted from the cells by adding 0.5 mL 100 
% isopropanol to each well of the 12-well plate. After 10 minutes of incubation the 
isopropanol was carefully collected.  
To quantify the amount of ORO in exposed and non-exposed cells, 150 µL isopropanol 
eluate, and a blank sample containing 100 % isopropanol, were transferred to a 96-well plate, 
and the absorbance of light at 500 nm wavelengths was measured. Measurements were 
conducted in duplicates. 
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3.5 MOLECULAR CLONING OF GENE SEQUENCE FRAGMENTS 
Molecular cloning is process used for replicating DNA fragments of interest by inserting 
recombinant DNA, consisting of the desired DNA sequence and a cloning vector, into a host 
organism for replication (Primrose et al., 2006). Results from this part can be found in 
Appendix B. 
3.5.1 RNA extraction, purification and quality assessment 
RNA needed to be extracted from the cells for subsequent molecular cloning and real-
time Q-PCR analysis. Total RNA was extracted with AurumTM Total RNA Mini Kit (Bio-
Rad), according to the manufacturer’s protocol. The kit uses guanidine isothiocyanate and 
β-mercaptoethanol to lyse samples and inactivate RNase. As real-time Q-PCR is a very 
sensitive technique of mRNA detection, it is crucial to obtain RNA free from residual 
genomic DNA, as this can result in false positives and background. DNase 1 digest was 
included in the kit. The extracted RNA was stored at -80 ºC. 
The concentration and purity of extracted total RNA was measured using a Nanodrop® 
ND-1000 spectrophotometer, which takes advantage of the fact that nucleic acids absorbs at 
260 nm and proteins at 280 nm. The 260/280 ratio was used to indicate the purity of RNA 
and DNA, at ratios of 2.0 and 1.8, respectively, even though the validity of using this ratio 
in regards to evaluating purity of nucleic acid preparations have been questioned (Glasel, 
1995).  
RNA integrity was assessed using denaturing agarose gel electrophoresis (denaturing 
AGE). Most RNA forms secondary structures, which can influence the mobility of RNA in 
the gel. These structures can be denatured by heat or denaturing agents, such as formamide, 
which keeps RNA denatured by preventing reformation of secondary structures (Masek et 
al., 2005). The presence and quantity of 28S and 18S ribosomal RNA (rRNA) was used to 
assess RNA integrity. 
One hundred ng of total RNA in 50 % formamide containing 1 x loading buffer was 
heated at 65 ºC for 10 minutes to denature RNA secondary structures. The denatured RNA, 
and 2-log DNA ladder, was subjected to electrophoresis (0.7 % agarose, 0.5 x TBE buffer 
(Table 2.3.)) for 40 minutes at 100 V. Before visualization of RNA under UV light, gels 
were incubated on shaker for 10 minutes in 0.5 x TBE buffer with 0.4 mg/mL EtBr.  
3.5.2 Complementary DNA synthesis 
Complementary DNA (cDNA) was synthesized from extracted RNA using the enzyme 
reverse transcriptase, oligo(dT) and hexamer primers, provided by iScriptTM cDNA synthesis 
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kit (Bio-Rad). 0.5 µg total RNA was used for each reaction and the cDNA synthesis was 
performed according to the suppliers protocol. A no reverse transcriptase control was 
prepared, to ensure that all genomic DNA had been digested during purification. 
3.5.3 Amplification of DNA by polymerase chain reaction 
Polymerase chain reaction (PCR) is used to exponentially amplify DNA segments 
(Mullis and Faloona, 1987). There are three different steps in a PCR: Denaturation of DNA, 
annealing of sequence specific primers, and extension of DNA strands by a thermostable 
DNA polymerase, such as Taq polymerase.  
A fragment of polar bear leptin (LEP) and tyrosine 3/tryptophan 5-monooxygenase 
activation protein (YWHAZ) was amplified using sequence specific primers (Table 2.9.). For 
each reaction a no template control (NTC) was prepared, to ensure that there was no 
contamination or non-specific amplification. A no reverse transcriptase control was also 
loaded, to verify that the samples were free from genomic DNA. PCR was performed on 
cDNA according to Tables 3.4. and 3.5. 
Table 3.4. Reaction solution for PCR 
Reagent Quantity 
10X Green DreamTaq Buffer 1x 
dNTP Mix 0.2 mM 
Forward primer 0.5 µM 
Reverse primer 0.5 µM 
DreamTaq DNA Polymerase 0.63 U 
cDNA (from 0.5 g RNA) 0.5 µL 
Deionized water  
Total 25 µL  
 
Table 3.5. PCR thermal cycling conditions 
Step Temperature ºC Time Cycles 
Initial denaturation 95 2 min 1 
Denaturation 95 30 s  
Annealing 55/50* 30 s 30 
Extension 72 1 min  
Final Extension 72 5 min 1 
Store 4 ∞  
* Annealing temperature YWHAZ: 55  ºC; annealing temperature LEP: 50 ºC 
METHODS 
27 
 
3.5.4 Agarose gel electrophoresis (AGE) – DNA/PCR products 
PCR products, and 2-log DNA ladder, were loaded on 1 % agarose gel in in 0.5 x TBE 
buffer (Table 2.3.). Gels ran for 40 minutes at 100 V. Before visualization of PCR products 
under UV light, the gels incubated on shaker for 10 minutes in 0.5 x TBE buffer with 0.4 
mg/mL EtBr.   
3.5.5 Gel extraction of PCR products 
PCR products were subjected to AGE as previousy described (3.5.4). Products of the 
expected sizes were excised from the gel and PCR products were extracted using 
MicroElute® Gel Extraction Kit according to the manufacturers’ protocol. 
3.5.6 Subcloning of PCR products 
 Taq polymerase creates PCR products with 3´-end A-overhangs. The pSC-A cloning 
vectors have U-overhangs at the 5´-end, which enables base pairing. The recombinant DNA, 
consisting of cloning vector and DNA segment, is subsequently incorporated into a host cell 
for replication. 
Purified PCR products were subcloned using the StrataClone PCR Cloning Kit (Agilent 
Technologies). The supplier’s protocol was followed, with some modifications: 
The ligation reaction was performed as recommended by the manufacturer. 2 µL of the 
ligation reaction was gently mixed with 16-25 µL StrataClone SoloPack competent cells, 
and incubated on ice for 20 minutes. The cells were heat-shocked at 42 °C for 45 seconds, 
and then placed on ice for 2 minutes. The heat-shocked bacteria were added 250 µl pre-
warmed SOC medium and carefully mixed, following one hour incubation with agitation at 
37 ºC. Two different volumes of preculture, 15 and 150 µL, were seeded to LB-ager plates 
containing ampicillin for selection (Table 2.7.) and incubated over night at 37 °C. 
3.5.7 Identification of transformed bacteria by colony PCR 
Ampicillin resistant bacteria colonies were screened for recombinant DNA by using the 
pSC-A vector specific primers T3 and M13-20 (Table 2.10.), which annealed up- and 
downstream of the PCR product insertion site, respectively. 
Colonies were picked, smeared onto new LB-ager plates containing ampicillin (Table 
2.7.), and added to the reaction solution for PCR (Table 3.2.). A NTC was prepared for each 
PCR. Also, pSC-A cloning vector containing a gene sequence fragment of the ADIPOQ gene 
(previously prepared by Roger Lille-Langøy, University of Bergen) was used as a positive 
control. PCR products were evaluated by AGE (3.5.4).  
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3.5.8 Plasmid purification  
It was necessary to extract plasmids from host cells for further use. Colonies suspected 
to contain recombinant DNA, based on colony PCR results, were selected and inoculated in 
2 mL LB-ampicillin, (Table 2.6.) overnight on shaker at 250 rpm and 37 ºC.  
Small-scale purification of plasmid DNA from bacteria was performed using E.Z.N.A® 
Plasmid DNA Mini Kit 1 (Omega bio-tek), according to suppliers’ protocol. Genomic DNA 
and proteins were denatured and precipitated in lysed bacteria, while plasmids stayed in the 
solution. Plasmid DNA was transferred and bound to a DNA binding column during washing 
steps, and subsequently eluted. Concentration and purity of eluted DNA was measured 
spectrophotometrically using Nanodrop® (3.5.1). 
3.5.9 Sequencing of plasmids using Sanger sequencing  
Sanger sequencing is a DNA sequencing method which makes use of dideoxynucleotides 
(ddNTPs) as chain-terminating inhibitors of DNA polymerase (Sanger et al., 1977). When 
using dye-terminator sequencing each of the four ddNTPs contain a different fluorescent 
dye, which permits sequencing in a single reaction. 
The sequencing reaction was carried out using BigDye version 3.1, according Table 3.6. 
and 3.7. After thermal cycling, the sequencing reaction was added 10 µL of deionized water. 
The DNA Sequencing Facility at the Department of Molecular Biology at the University of 
Bergen conducted the separation of sequencing reaction products and base calling. 
Table 3.6. Sequencing reaction solution for Big-Dye version 3.1. 
Reagent Quantity 
BigDye v.3.1 1 µL 
Sequencing buffer 1 µL 
Template 200 ng 
M13-20 primer 3.2 pmol 
Deionized water  
Total 10 µL  
 
Table 3.7. Thermal cycling conditions for Big-Dye version 3.1.  
Step Temperature ºC Time Cycles 
Initial denaturation 96 5 min 1 
Denaturation 96 10 s  
Annealing 50 5 s 35 
Extension 60 4 min  
Store 4 ∞  
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3.5.10 Restriction endonuclease digestion 
Plasmids needed to be linearized before use in real-time Q-PCR. Restriction enzymes, 
which recognize and cut specific sequences in double stranded DNA, preforms restriction 
digestions. The digestion can be evaluated using AGE, as plasmids have different shapes 
depending on the number of intact DNA strands. Uncut plasmids have the shape of a 
supercoiled helix, and therefore runs faster through the gel than linearized plasmids. 
Plasmids with one nicked DNA strand have the shape of an open circle, and thereby runs 
slower through the gel (Primrose et al., 2006). 
Restriction digestions were composed according to Table 3.8., and carried out at 37 ºC 
for 2 hours, and subsequently evaluated by AGE (0.4 % agarose (3.5.4)). Linearized 
plasmids were purified using GenEluteTM PCR Clean-Up Kit (Sigma-Aldrich), according 
to the suppliers’ protocol. Concentration and purity of linearized plasmids were measured 
using Nanodrop® (3.5.1). The digestion success and integrity of the plasmids were evaluated 
with AGE as previously described. 
Table 3.8. Restriction digestion reaction for YWHAZ and LEP plasmids (pSC-A) 
Reagent Volume (µL) [Final] Reagent Volume (µL) [Final] 
Buffer M 7 1X Buffer H 7.5 1X 
BSA 7 0.01 % BSA 7.5 0.01 % 
pSC-A YWHAZ 50 4.3 µg Triton X-100 7.5 0.01 % 
Xba I 0.6 9 U pSC-A LEP 45 5.8 µg 
Deionized water 5.4   Not I 1 10 U 
      Deionized water 6.5   
Total volume 70   Total volume 75   
 
3.6 MEASURING TRANSCRIPT LEVELS USING REAL-TIME 
QUANTITATIVE PCR  
Real time Q-PCR is a sensitive method used for quantifying the transcript levels of 
desired genes present in a sample (Bustin, 2000). In this study we investigated the transcript 
levels of the adipocyte specific genes PPARγ, FABP4, and LEP. SYBR green binds to double 
stranded DNA, and after each cycle of amplification the fluorescence of the bound dye is 
measured. Ideally the PCR product doubles during the exponential phase of PCR, and 
eventually the fluorescence from the amplification exceeds the background, which is known 
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as the detection threshold (CT) value. At which cycle CT is reached, depends on the initial 
transcript copy number (Heid et al., 1996). Two reference genes were used to normalize 
samples for relative quantification. Reference genes have stable transcript levels, which 
should not be affected by experimental conditions. We chose to use tyrosine 3/tryptophan 5-
monooxygenase activation protein (YWHAZ) and cyclophilin A (PPIA) as reference genes, 
as they have been verified as stable reference genes in ASCs (Fink et al., 2008).  We chose 
to use two reference genes for normalization, as this measures expression levels more 
accurately, and calculate the normalization values as a geometric mean, as recommended by 
Vandesompele et al. (2002). The use of geometric mean adjust for the fact that housekeeping 
genes are expressed at different levels. Melting curves was used to evaluate the specificity 
of the amplification products. 
All real-time Q-PCR samples were prepared using iQ™ SYBR® Green Supermix (Table 
3.9.). The real-time Q-PCR was performed using LightCycler® 480, according to Table 
3.10. For all assays there was a no template control (NTC) and a calibrator sample. 
Measurements were conducted in triplicates. The results were analyzed using the 
LightCycler® 480 software. 
Standard curves were created by serial dilutions of linearized pSC-A plasmids containing 
the selected gene sequences (PPARγ, FABP4, LEP, YWHAZ or PPIA). From these the 
amplification efficiencies for the reactions were calculated. These values were used during 
normalization of samples. Also, 1:10, 1:20 and 1:40 dilutions of pooled cDNA were 
measured, to evaluate which dilution factor was most suitable. Detailed procedure and 
results from these assays can be found in Appendix C. 
To examine the transcript levels of the three target genes during different stages of 
adipocyte differentiation, RNA was extracted (3.5.1) from cells 2, 6, 10 and 14 days after 
induction by BM or MDI medium, supplemented with DMSO or ROSI (Table 3.2. and 3.3.). 
Otherwise the general adipogenic procedure was followed (3.3.1). cDNA was synthesized 
(3.5.2) and real-time Q-PCR was performed as previously described. The experiment was 
conducted once, in duplicates. 
Reference gene stability was evaluated by inserting the measured CT values of YWHAZ 
and PPIA from the above experiment into RefFinder (leonxie.com/referencegene.php) 
(Appendix C).  
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Table 3.9. Reaction solution for real-time Q-PCR 
Reagent Quantity 
2x iQ™ SYBR® Green Supermix 1x 
Forward primer 300 nM 
Reverse primer 300 nM 
cDNA (1:10 dilution) 5 µL 
Ultrapure water  
Total 20 µL  
 
Table 3.10. Real-time Q-PCR thermal cycling conditions 
Step Temperature (ºC) 
Hold 
time 
Ramp Rate 
(ºC/s) Cycles 
Acquisitions 
(per ºC) 
Pre-incubation 95 3 min 4.40 1  
Amplification      
Denaturation 95 10 s 4.40   
Annealing 50/57/60* 30 s 2.20 30  
Extension 72 30 s 4.40   
Melting curve      
Denaturation 95 5 s 4.40   
Lowest  65 1 min 2.20   
Highest 97  0.11 1 5 
Cooling 40 30 s 2.20   
* Annealing temperatures: LEP: 50 ºC; PPIA, PPARγ and FABP4: 57 ºC; YWHAZ: 60 ºC. 
3.7 STATISTICAL ANALYSIS 
To evaluate the effect of media or test compounds on adipogenesis the results were made 
relative to control samples, and the statistical validity evaluated using a paired, two-tailed t-
test.
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4 RESULTS 
4.1 GENERAL OBSERVATIONS REGARDING CULTIVATION OF pbASCs 
4.1.1 Proliferation, shape, and size of pbASCs 
PbASCs were expanded in GM (Table 2.5.) and subcultured at approximately 70 % 
confluence (3.2.2). It took approximately one to one and a half week for cells seeded at a 
density of 3000 cells/cm2 (i.e. approximately 15 % confluence) to reach 70 % confluence. 
During this period the number of cells could increase with a factor of 3 to 6, mainly 
depending on the shape of the cells.  
Cultured pbASCs grew in an adherent monolayer (Fig. 4.1.). In early passages the cells 
were uniform in shape, based on visual observation by an inverted microscope. They were 
thin, small, and spindle-shaped (Fig 4.1.A.). Wider, larger and triangular-shaped cells started 
to appear (Fig 4.1.B.), when subcultured into higher passages, and the culture dishes 
contained areas dominated by one of the two cell shapes, in varying degrees. When initial 
seeding density was kept constant, it was observed that cultures containing mainly the larger 
cell type used longer time to reach 70 % confluence compared to cultures that primarily 
contained the smaller cell type. This could suggest that the larger cells were proliferating 
more slowly than the smaller cells. 
 
 
Figure 4.1. Cell shape and size of pbASCs. PbASCs were cultured in GM and subcultured when 
approximately 70 % confluence was reached. Cells were visualized by inverted microscopy with a 
10x objective. A) spindle-shaped pbASCs in passage 2. B) Triangular-shaped pbASCs in passage 7. 
  
A)     B) 
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4.1.2 Confluence and cell contact inhibition 
PbASCs were generally subcultured at approximately 70 % confluent, but we wanted to 
investigate if reaching confluence during subculturing affected the cells contact inhibition. 
Cells that had been subcultured at 70 % confluence and cells that had reached confluence 
during subculturing, were cultured to confluency and maintained in culture for 37 days 
(3.2.2) 
It was observed that cells that previously had been confluent, did not stop growing, but 
started to grow on top of each other (Fig 4.2.A.). Also, 37 days after 100 % confluence the 
cells were dying, observed as empty fields in the well. Cells that had not previously been 
confluent remained in a monolayer for a long period of time. At day 37 the cells still 
remained viable, but overgrowing was observed (Fig 4.2.B.). This may indicate that reaching 
confluency during subculturing leads to loss of contact inhibition.  
 
Figure 4.2. Effect of confluence level of pbASCs during cultivation on contact inhibition.  Cells, 
in passage 7, that had been 100 % confluent during subculturing (A), and cells, in passage 5, that had 
never been above 70 % confluent (B), were cultured to 100 % confluence in 6-well plates and 
maintained in that culture for 37 days. Cells were visualized by inverted microscopy with a 10x 
objective.
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4.2 ESTABLISHMENT OF CONDITIONS FOR ADIPOGENIC 
DIFFERENTIATION OF POLAR BEAR ADIPOSE TISSUE-DERIVED STEM 
CELLS (pbASCs) 
As adipose tissue-derived stem cells from polar bears have not previously been studied 
to our knowledge, suitable conditions for adipogenic differentiation needed to be established. 
This was done by testing seven adipogenic induction media which differed in concentrations 
of adipogenic inducers (Table 3.1.). 
4.2.1 Conditions allowing adipogenic differentiation of pbASCs  
Attempts to induce adipogenic differentiation in pbASCs essentially as described by Fink 
et al (2008) proved unsuccessful. Using this method, cells were induced by MII200 (Table 
3.1.), following the general procedure (3.3.1). As it was uncertain how long the cells needed 
to be induced before the adipogenic conversion was apparent, cells were induced for two 
different periods of time. Half of the cells were induced for one week, while the other half 
was induced for three weeks, as no adipogenic differentiation was apparent after two weeks.  
A high level of cell death in MDII200 induced cells was observed visually, by using an 
inverted microscope, as the presence of detached, floating cells, which resulted in a reduction 
in confluence during cultivation. This could indicate that the pbASCs responded negatively 
to the MII200-medium. Also, no staining of the cells by Oil red O (ORO) could be observed, 
indicating a lack of triglyceride accumulation and thereby absence of adipogenic 
differentiation (Fig. 4.3). It was also observed that cells not stimulated for differentiation 
(cultivated in GM) did not stop to proliferate after confluency was reached, as cells were 
growing on top of each other in week three (Fig. 4.3.). A possible reason for this could be 
that the cells had lost the property of contact inhibition during cultivation, as the cells used 
in this experiment previously had been confluent (4.1.2). This could subsequently affect the 
cells capability to undergo adipogenic differentiation as growth arrest is a requirement for 
adipogenesis to occur. 
RESULTS 
35 
 
 
 
Because of the suspected negative response of the pbASCs to one or more 
components in the MDII200-medium, and the possible interference of using cells that had 
previously been confluent, a new experiment was conducted (3.3.1). PbASCs, which were 
constantly kept at < 70 % confluence during subculturing at all passages, were induced for 
14 days to seven various AIMs (Table 3.1.) containing different adipogenic inducing 
compounds, including IBMX, INDO, DEX and ROSI. Non-induced control cells were 
cultured in BM. 
Visual inspection of ORO-stained cells revealed that all sample wells with cells 
receiving AIMs contained cells who had accumulated lipids in vacuoles, to varying extents, 
while no lipid accumulation was observed in wells containing non-induced control cells (Fig. 
4.4.A.). However, cell death were observed in all wells receiving media containing 200 µM 
INDO (MII200, MDII200 and MDII200R) (Fig. 4.4.B.), indicating that 200 µM INDO might 
be toxic for pbASCs.  
GROWTH MEDIUM                MII200-MEDUIM 
1 WK 
3 WKS 
Figure 4.3. PbASCs cultured in growth medium or MII200-medium. Confluent 
pbASCs in passage 8 was cultured in 6-well plates in GM, or in the adipogenic induction 
medium MII200, for 1 or 3 weeks, and subsequently fixed and stained with Oil Red O. 
Cells were visualized by inverted microscopy with a 10x objective. 
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Figure 4.4. Effect of various adipogenic induction media on lipid accumulation in pbASCs. 
PbASCs were cultured in AIMs for two weeks, and subsequently fixed and stained with Oil Red O 
(ORO). A) Cells were visualized by inverted microscopy with 10x and 40x (bottom right) objectives. 
The red droplets are lipids stained by ORO. B) The absorbance (λ=500 nm) in isopropanol extracts 
was measured to quantify lipid content. Cells were seeded in 6-well culture plates and in triplicates 
(n=3). † = high level of cell death (observed by inverted microscopy as detached cells floating in the 
medium and a decrease in confluence to below approximately 70 % or less during cultivation). ** = 
significantly different from undifferentiated control cells, P<0.01.  
CONTROL                      MII200 
MDI+ROSI                   MDI+ROSI (40x)                                
A) 
B) 
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Cells receiving media containing 50 µM INDO (MII50, MDII50, and MDII50R) 
showed less signs of distress, and lipid content measured by eluted ORO from the cells were 
significantly higher than (P<0.01) in non-induced control cells. Cells receiving IBMX, DEX, 
and ROSI, but no INDO (MDI+ROSI), had the highest lipid content with an approximately 
three-fold increase in lipid content compared to the control cells (P <0.01). Comparable lipid 
content was observed in cells receiving MDII50R-medium, while the lipid content in cells 
cultured in MDII50- and MII50-medium was approximately twice as high as in the control 
cells (P<0.01). 
4.2.2 Effect of rosiglitazone on adipogenic differentiation in MDI medium 
The effect of ROSI on adipogenic differentiation was investigated by inducing cells in 
MDI+ROSI (Table 3.1.), or MDI+ 0.1 % DMSO for two weeks, following the general 
induction protocol (3.3.1). Lipid content, measured using ORO-staining, was almost three 
times higher in cells receiving MDI+ROSI compared to the cells receiving MDI (P<0.01), 
indicating that 1 µM ROSI strongly induce adipogenic differentiation in pbASCs (Fig. 4.5.). 
The lipid content in cells induced by MDI was double the measured content in the control, 
indicating that the MDI medium induces adipocyte differentiation, but in a less extent than 
MDI+ROSI. Due to this, it was decided that MDI-medium could be used as a differentiated 
control with a low level of differentiation, which allows for discrimination of effects of the 
test chemicals, in future experiments.  
 
Figure 4.5. Effect of rosiglitazone on lipid accumulation in pbASCs. PbASCs were cultured in 
basal medium (GM supplemented with 1 µg/ml insulin, and 0.2% DMSO), MDI (0.2 % DMSO) or 
MDI+ 1 µM ROSI for two weeks, and subsequently fixed and stained with Oil Red O (ORO). The 
absorbance (λ=500 nm) in isopropanol extracts was measured to quantify lipid content. Cells were 
seeded in duplicates (n=2) in 6-well culture plates (n=2). * = significantly different from MDI, 
P<0.05.  
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4.3 TRANSCRIPT LEVELS OF ADIPOCYTE SPECIFIC GENES DURING 
DIFFERENT STAGES OF ADIPOGENIC DIFFERENTIATION 
Polar bear ASCs were induced for 2, 6, 10, or 14 days in MDI-medium, supplemented 
with 1 µM ROSI or DMSO, or maintained in BM, as non-induced controls (Table 3.2), 
before RNA was extracted from the cells (3.5.1). cDNA was synthesized (3.5.2) and 
expression levels of adipogenic genes were measured. The transcript levels of all target 
genes, PPARγ, FABP4, and LEP, were normalized against the reference genes, before 
relative quantification against control samples were executed. 
 
4.3.1 MDI and ROSI induce transcription of PPARγ in pbASCs 
PPARγ transcript levels in non-induced cells cultivated in BM remained relatively stable 
throughout the 14 day cultivation period (Fig. 4.6.A.), as an 1.1-fold increase in transcript 
levels were measured the on day 6, 10 and 14, compared to transcript levels on day 2. This 
indicates that BM did not affect the expression of PPARγ in the non-induced cells. Cells 
induced by MDI, without ROSI, had an increased expression of PPARγ from day 2 to day 6, 
and remained stable from day 6-14, and the expression of PPARγ were lower than in cells 
induced by MDI+ROSI. Six days after induction the transcription levels of PPARγ in cells 
induced by MDI+ROSI were over 30 times higher than in non-induced cells, and 3 times 
higher than in cells induced by MDI alone, at day 6. The PPARγ levels remained unchanged 
until day 10, but had decreased by 30 % by day 14. This shows that exposure to ROSI induces 
PPARγ transcription in pbASCs. 
4.3.2 Transcription levels of FABP4 are elevated during adipogenesis in pbASCs 
The mRNA expression of FABP4 was elevated in cells induced by MDI and MDI+ROSI 
compared to the non-induced cells cultured in BM throughout the 14 day induction period 
(Fig. 4.6.B.). Transcription levels of FABP4 were 84 and 2692 timer higher in MDI and 
MDI+ROSI induced cells compared to the cells cultured in BM at day 14. FABP4 transcript 
levels were also higher in cells induced by MDI+ROSI than in cells induced by MDI (30 
times higher on day 14). The mRNA expression of FABP4 in cells cultured in BM were 
increasing during the culturing period, and at day 14 the transcript levels were 12 times 
higher compared to day 2.  
4.3.3 Transcription of LEP is elevated by MDI induction 
The transcript levels of LEP were highest two days after induction (5.6 and 3.6 times 
higher in MDI and MDI+ROSI induced cells, respectively) and remained stable from day 6 
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until the end of the experiment (Fig. 4.6.C.). Except from on day 2, LEP levels appeared to 
be independent of ROSI, and the LEP gene expression was continuously higher in 
MDI/MDI+ROSI exposed cells than in BM cultured cells (average of 3 times higher from 
day 6 to day 14).  
 
Figure. 4.6. Relative transcript levels of PPARγ, FABP4 and LEP during different stages of 
adipogenic differentiation of pbASCs. RNA was extracted from pbASCs cultured in BM or MDI 
medium, supplied with o.1% DMSO or 1 µM ROSI, for 2, 6, 10 or 14 days. Subsequently cDNA 
synthesis was performed and real-time Q-PCR conducted. Transcript levels were normalized against 
the reference genes WYHAZ and PPIA, and the expression made relative to that of the control cells 
(cells cultivated in BM for 2 days). Cells were seeded in duplicates (n=2).  Two samples were omitted 
from the analysis (MDI Day 6, and BM day 14) due to lack of a valid CT value, or extreme aberration. 
* = significantly different from control cells, P<0.05; ** = significantly different from control cells, 
P<0.01. 
  
A) 
B) C) 
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4.4 EFFECTS OF EXPOSURE TO ENDOCRINE DISRUPTING CHEMICALS ON 
ADIPOGENIC DIFFERENTIATION IN pbASCs 
PbASCs were exposed to two known EDCs, mono(2-ethylhexyl)phthalate (MEHP) and 
bisphenol A (BPA), supplemented in BM or MDI medium for 14 days (3.3.2). The 
experiments were repeated twice (experiments A and B). Cells were stained with Oil red O 
to quantify lipid content and mRNA expression was studied by real-time Q-PCR in parallel 
experiments, using cells from the same culture flasks, and the same prepared media, to obtain 
the most similar conditions possible. 
4.4.1 Quantification of lipid content by Oil Red O staining 
When evaluating experiment A and B together (Fig. 4.7.A.) a significant (p<0.05) 
increase in lipid content was observed in cells exposed to 50 µM MEHP, both in BM and 
MDI medium, compared to non-exposed control cells. Further, results from experiment A 
alone showed that MDI medium supplemented with 10 µM MEHP also increased lipid 
content, while 50 μM MEHP was needed to increase lipid content in the cells in experiment 
B (Fig. 4.7.B and C.). 
Exposure to BPA did not result in any change in lipid content compared to the control 
cells in the overall results (A+B). Although, in experiment A, both 10 and 50 µM BPA (in 
MDI-medium) reduced lipid accumulation compared non-induced control cells.  
The highest lipid content was measured in cells cultured in MDI + ROSI. In these cells 
the lipid content was three times higher compared to the MDI + DMSO control cells. 
This inter-experimental variation might have a technical explanation. Some problems 
were encountered during ORO staining of experiment B (Fig. 4.7.C.). During the procedure 
differentiated cells detached, observed in the microscope as areas without cells in the wells. 
This leads to an uneven amount of differentiated cells to stain with ORO, and subsequently 
quantify, compared to experiment A. Also, small crystals of ORO had attached to the cell 
layer, as observed in the microscope (Fig. 4.7.D.). Through the microscope one could clearly 
see that the crystals were stuck on top of the cells, and not absorbed inside the cells in lipid 
vacuoles. After elution of ORO these crystals can lead to a higher measured absorbance, and 
successively a higher measured lipid content. These two factors have likely contributed to 
some of the variance in results from the experiments. 
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Figure. 4.7. Effect of MEHP or BPA on lipid accumulation in pbASCs. PbASCs were cultured 
in for two weeks in BM or MDI, supplemented with BPA, MEHP, ROSI, or DMSO (0.1%), and 
subsequently fixed and stained with Oil Red O (ORO). The absorbance (λ=500 nm) in isopropanol 
extracts was measured to quantify lipid content. A) Graph showing the overall results (n=6). B) and 
C) Results from each individual experiment (n=3).  D) ORO crystals attached to the cell layer 
(inverted microscope, 10x objective). * = significantly different from control cells (undiff or DMSO), 
P<0.05; ** = significantly different from control cells (undiff or DMSO), P<0.01. 
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4.4.2 Transcript levels of adipocyte specific genes measured by real-time Q-PCR 
Due to time constraints, transcript levels were only measured from one of the two 
experiments aimed to study changes in the expression of selected adipogenic genes after 
exposure to EDCs (4.4.1,experiment A). The transcript levels of all target genes, PPARγ, 
FABP4, and LEP, were normalized against the reference genes, YWHAZ and PPIA, before 
relative quantification against the undifferentiated control samples was executed. 
4.4.2.1 MDI medium and ROSI induce the transcription of adipogenic genes in pbASCs 
Results showed that the transcript levels of all target genes were noticeably higher in 
differentiated control cells cultured in MDI+DMSO compared to undifferentiated control 
cells cultured in BM+DMSO (p<0.01) (Fig. 4.8.). Especially the transcript levels of PPARγ 
and FABP4 were increased (by 19- and 18-fold, respectively). This was expected as the 
MDI-medium contains the adipogenic inducers DEX and IBMX, in addition to insulin. Cells 
cultured in MDI+ROSI resulted in an even higher transcript level of all target genes 
(P<0.01), also here especially of PPARγ and FABP4 (36- and 400-fold, respectively). This 
indicates that ROSI is a PPARγ agonist and adipogenic inducer also in pbASCs.  
4.4.2.2 MEHP increases transcription of PPARγ, FABP4 and LEP in pbASCs 
All three MEHP treatments (BM+50 μM, MDI+10 μM and MDI+50 μM) resulted in 
significantly (P<0.01) higher transcript levels of PPARγ and FABP4, compared to non-
exposed control cells (undiff and DMSO) (Fig. 4.8.A and B.). A 1.2-fold increase in 
transcript levels of LEP in cells subjected to BM+50µM MEHP was measured, while no 
change was detected in cells subjected to MEHP in MDI medium on LEP gene expression, 
compared to control cells (Fig. 4.8.C.). 
4.4.2.3 Effect of BPA on PPARγ dependent on MDI-induction 
Cells exposed to BPA had an increase of 1.2-fold on transcript level of PPARγ when 
subjected to BM+50 µM BPA, while a 2.4-fold decrease was measured in cells subjected to 
MDI+ 50 µM BPA (Fig. 4.8.A.). Exposure to BPA did not result in change of transcription 
levels of FABP4 (Fig. 4.8.B.). 
4.4.2.4 BPA inhibits mRNA expression of LEP in pbASCs 
All three BPA treatments (BM+50 μM, MDI+10 μM and MDI+50 μM) resulted in lower 
transcript levels of LEP, compared to the controls (Fig. 4.8.C). In cells not induced by MDI, 
BPA reduced LEP transcripts by 1.35 fold, while in MDI-induced cells LEP was inhibited 
by 1.6- and 2.3-fold when exposed to 10 and 50 µM BPA, respectively. 
RESULTS 
43 
 
 
Figure 4.8. Effect of MEHP or BPA on transcript levels of PPARγ, FABP4 and LEP in pbASCs. 
PbASCs were seeded in duplicates (n=2) and cultured in for two weeks in BM or MDI, supplemented 
with BPA, MEHP, ROSI, or DMSO (0.1%), before RNA was extracted and synthesis of cDNA was 
conducted. Transcript levels were measured by real-time Q-PCR, and normalized against reference 
genes (WYHAZ and PPIA). Two samples were omitted from the FABP4 results (MDI+50 µM BPA, 
and MDI+1 µM ROSI) due to lack of a valid CT value, or extreme aberration. * = significantly 
different from control cells (undiff or DMSO), P<0.05; ** = significantly different from control cells 
(undiff or DMSO), P<0.01. 
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5 DISCUSSION 
In this thesis, I have demonstrated that adipose tissue-derived stem cells from polar 
bear (pbASCs) can be successfully maintained and propagated in culture. In addition, the 
cells were shown able to differentiate to adipocytes when induced by adipogenic stimuli.  
In this work effects of test chemicals (EDCs) on adipogenic conversion were also shown. 
This was done by measuring changes in lipid content and transcript levels of adipocyte 
specific genes (PPARγ, FABP4 and LEP) in pbASCs. Exposure to the known EDCs 
mono(2-ethylhexyl)phatalate (MEHP) and bisphenol A (BPA) indicated that adipogenic 
differentiation is induced by MEHP, but not by BPA in pbASCs, at the tested 
concentrations. In this chapter, these findings will be discussed in relation to relevant 
literature. 
5.1 ISSUES REGARDING CULTIVATION OF POLAR BEAR ADIPOSE-TISSUE 
DERIVED STEM CELLS 
5.1.1 Cell isolates from polar bear adipose tissue possess several characteristics of 
mesenchymal stem cells 
Mesenchymal stem cells (MSCs) are stromal cells that are able to self-renew and to 
differentiate into several different cell types. MSCs can be obtained from sources such as 
bone marrow and adipose tissue, and MSCs derived from these two tissues are denoted as 
BMSCs and ASCs, respectively. The International Society for Cellular Therapy (ISCT) have 
formulated three minimum criteria to define multipotent human MSCs (and for the following 
discussion it is assumed that these criteria also are valid for polar bear MSCs); the cells must 
adhere to plastic when maintained in culture, they must have a specific surface antigen 
expression, and be able to differentiate into adipocytes, osteoblasts, and chondroblasts in 
vitro (Dominici et al., 2006).  
In this study polar bear MSCs isolated from adipose tissue (pbASCs) was shown to 
adhere to plastic (4.1.1), thus possessing the first of three MSC characteristics. Furthermore, 
it was shown that the cells were capable of adipogenic differentiation, through Oil Red O 
staining (4.2.1) and transcriptional analysis of adipocyte specific genes (4.4). This confirms 
that the pbASCs could differentiate to adipocytes. However, to fully characterize the isolated 
polar bear cells as multipotent ASCs, their capabilities of differentiating towards the 
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osteogenic and chondrogenic lineages would need to be confirmed. It should also be 
investigated if the cells have the stem cell specific expression of surface antigens (Dominici 
et al., 2006), for example by immunostaining assays. 
5.1.2 Initial seeding density of pbASCs 
As pbASCs are costly and laborious to obtain, it was important to utilize the cells in the 
best possible manner. To conduct the experiments in this study a large amount of cells was 
needed, therefore a substantial expansion of the cells was conducted.  
Several studies have shown that MSCs proliferate faster at low seeding densities 
(Bartmann et al., 2007, Lode et al., 2008). A study by Mochizuki et al. (2006) found that the 
optimal initial seeding density for maximizing cell yields per dish were 1000 cells/cm3, while 
others recommend to seed MSCs at 100 cells/cm3 (Lund et al., 2009, Both et al., 2007). 
Because we had limited time to use for cell expansion an initial seeding density of 3000 
cells/cm2 was used for the most part of this study, as this allows for the expansion of more 
cells at the same time than lower densities. Seeding cells at a higher density reduces the time 
needed to obtain the necessary amount of cells, at the expense of a poorer utilization of the 
isolated pbASCs. When seeded at 3000 cells/cm2, the number of cells could increase up to 
six times before subculturing at 70% confluence (4.1.1). Seeding cells at this density 
presumably do not affect the potential of the cells to differentiate, as it previously have been 
shown that seeding cells at 5000 cells/cm3 or 100 cells/cm3 did not affect the differentiation 
potential of human BMSC (Both et al., 2007). 
5.1.3 Cell density during expansion 
A more crucial factor regarding cell density and differentiation potential is cell density 
during expansion. It has been found that human ASCs harvested at 50% confluence or 90% 
confluence have different gene expression patterns of genes involved in processes such as 
proliferation, cell communication, signal transduction and motility (Kim et al., 2014). As 
reaching confluence during culturing can modify expression patterns of ASCs, it is important 
to maintain the cells at a subconfluent level. However, it has been found that changes in the 
expression of genes involved in contact inhibition did not affect the ability to differentiate 
in ASCs derived from mouse (Jeon et al., 2012).  
In this study it was observed that pbASCs allowed to reach 100% confluency during 
culturing behaved differently from cells that had been maintained at subconfluency (4.2.2). 
The previously confluent cells did not stop growing after reaching confluence, perhaps due 
to loss of contact inhibition. It is possible that this could affect the cells’ capability to undergo 
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adipogenic differentiation as growth arrest is a requirement for adipogenesis to occur. The 
mechanisms of how growth arrest is regulated still remains unclear, but both peroxisome 
proliferator-activated receptor gamma (PPARγ) and CCAAT-enhancer-binding protein 
alpha (C/EBPα) are involved in the regulation (Gregoire et al., 1998). In adipogenic 
induction media (AIM), the adipogenic inducers dexamethasone (DEX), 3-isobutyl-1-
methylxanthine (IBMX), and rosiglitazone (ROSI) induce the expression of PPARγ and 
C/EBPα, directly or indirectly. With this in mind, it could be interesting to study if 
confluence during subculturing leads to loss of contact inhibition, and if this in turn affects 
the cells’ capability to undergo differentiation. 
5.1.4 Time spent in culture 
A previous study using rat BMSCs has shown that the amount of time cells spend in 
culture can affect morphology and lead to loss of differentiation ability (Neuhuber et al., 
2008). In our study it was observed that the cultured pbASCs had a small and spindle shaped 
appearance in early passages, but in higher passages larger, triangular shaped cells were 
observed (4.1.1). These larger cells seemed to proliferate at a slower rate than the smaller 
cells. These observations are in accordance with several other studies (Sekiya et al., 2002, 
DiGirolamo et al., 1999, Bruder et al., 1997, Wagner et al., 2008). The results from those 
studies indicated that the large, wider cells have a reduced differentiation potential, and also 
that this appearance is a sign of senescence, but this was not investigated in our study. To 
avoid variation in cell shape and possibly differentiation potential, cells in same low passage 
numbers should be used to study adipogenic potentials of pbASCs. 
5.2 CHOICE OF ADIPOGENIC MEDIUM AND INDUCTION PERIOD 
To our knowledge, this is the first study on ASCs from polar bear (pbASCs). Thus, 
conditions for induction of adipogenic differentiation of pbASCs needed to be established. 
However, methods for inducing adipogenic differentiation of ASCs from other species, such 
as human, mouse and brown bear, have been described but the conditions used often vary 
(reviewed by Scott et al., 2011). In this study, seven different AIMs, which contained various 
concentrations of the adipogenic inducers IBMX, DEX, ROSI and indomethacin (INDO),  
(Table 3.1.), were tested to find the most effective AIM for the differentiation of pbASCs. 
Visual inspection of Oil Red O (ORO) stained cells revealed that all seven AIMs had resulted 
in triglyceride accumulation, but to varying degrees (4.2.1). However, pbASCs may be more 
sensitive to INDO than human and brown bear ASCs (Fink et al., 2008, Fink et al., 2011), 
as a high level of cell death was observed for cells receiving media containing 200 µM 
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INDO, while cells induced by 50 µM INDO showed less sign of distress. No previously 
published data on toxic effect of INDO could be found, but a study by Scott et al (2011) 
found differences in the concentration of adipogenic inducers used for optimal 
differentiation of human and mouse MSCs. This could indicate that there are species 
differences in sensitivity to adipogenic inducers. The highest lipid content was found in cells 
induced by MDI+ROSI which contained 1 µM of the PPARγ ligand ROSI and no INDO. 
The contribution of ROSI on adipogenic differentiation was investigated by comparing lipid 
content of cells induced by MDI+ROSI or MDI (0.1% DMSO) (4.2.2). The lipid content in 
MDI+ROSI induced cells were three times higher than in cells induced by MDI, indicating 
that ROSI strongly induce adipogenic differentiation of pbASCs. This is in accordance with 
literature and the induction is probably due to the fact that ROSI is a ligand of PPARγ, which 
is required for adipogenic differentiation (Benvenuti et al., 2007, Rosen et al., 1999) 
As the highest concentration (200 µM) of INDO appeared to be toxic for the pbASCs, 
and the cells induced by MDI+ROSI had accumulated the most lipids, the MDI+ROSI 
medium composition was used as a positive control medium in the remain of the study, 
assuming that this medium induced a high level of adipogenic differentiation in the pbASCs. 
The MDI medium, without ROSI, induced a low level of adipogenic differentiation, and 
therefore could be used as a differentiated control, to allow for the discrimination of effects 
of test chemicals. 
In this study cells were continuously stimulated for 14 days, which is common for ASCs. 
Visual signs of triglyceride accumulation were however observed as early as 7 days after 
induction (results not shown). The possibility of shortening the induction period should be 
investigated, as a shorter induction period would save both time and materials.  
It could also be very interesting to investigate if it is enough to induce the cells by AIM 
rather than to maintain them in it, as both DEX and IBMX induce first wave transcription 
factors (TFs) of adipogenesis. This could be done by inducing the cells for a short period (2-
3 days) with AIM followed by maintaining the cells in basal medium (consisting of growth 
medium supplemented with insulin) similar to the protocols commonly used for 3T3-L1 
cells. 
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5.3 TRANSCRIPT LEVELS OF ADIPOCYTE SPECIFIC GENES IN pbASCs 
CHANGE DURING THE INDUCTION PERIOD IN RESPONSE TO 
ADIPOGENIC INDUCTION MEDIA 
Human BMSCs have been shown capable of accumulating lipids without transcribing 
adipocyte specific genes, which could indicate that the lipid accumulation occurred 
independently of adipogenic differentiation (Fink et al., 2004). Thus, is was necessary to 
confirm that the accumulation of lipids in the pbASCs was a result of adipogenic 
differentiation by measuring the transcript levels of the adipocyte specific genes peroxisome 
proliferator-activated receptor gamma (PPARγ), fatty acid-binding protein 4 (FABP4), and 
leptin (LEP) by real-time quantitative-PCR (real-time Q-PCR), after culturing the cells in 
three different media (BM, MDI or MDI+ROSI). RNA was extracted 2, 6, 10 and 14 days 
after induction, and the transcript levels were measured to investigate changes in expression 
during different stages of adipogenesis.  
5.3.1 MDI and MDI+ROSI induce transcription of PPARγ in pbASCs 
PPARγ is commonly used as an early marker of adipogenic differentiation, as the 
expression is turned on early during adipogenesis, and it is required for adipocyte 
differentiation (Chawla et al., 1994, Rosen et al., 1999). In the present study the expression 
of PPARγ remained relatively unchanged in non-induced cells cultured in BM, indicating 
that BM poorly induce expression of PPARγ in pbASCs (Fig. 4.6.A.). Cells cultured in MDI 
or MDI+ROSI medium had a higher expression of PPARγ compared to the non-induced 
control cells, and highest expression levels were measured on day 6 and 10 after induction. 
The expression was higher in cells induced by MDI+ROSI than in cells induced by MDI 
medium (3 times higher on day 6), indicating that ROSI also is a PPARγ ligand in polar 
bears. On day 14 the transcript levels in cells induced by MDI+ROSI had declined by 30 %, 
compared to day 10. This is in accordance with a previous study using 3T3-L1 cells, which 
found that the presence of PPARγ ligands can lead to a down-regulation of PPARγ 
expression during later stages of differentiation (Camp et al., 1999). Thus, it is possible that 
the presence of ROSI leads to similar effects in the pbASCs at this late stage of 
differentiation. 
5.3.2 Transcription levels of FABP4 are elevated during adipogenesis in pbASCs 
Transcript levels of FABP4, a target of PPARγ, were elevated in cells induced by MDI 
and MDI+ROSI, compared to non-induced control cells, during the 14 day induction period 
(Fig 4.6.B.). Also, transcript levels were substantially higher in cells induced by MDI+ROSI 
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than in cells induced by MDI (30 times higher on day 14), which was to be expected as ROSI 
activate PPARγ, which subsequently induces transcription of FABP4 (Tontonoz et al., 
1994). This indicates that ROSI activates PPARγ in polar bear and this activation may induce 
the expression of FABP4.  
An increase of FABP4 transcript levels was observed in non-induced control cells, 
cultured in BM during the induction period. A possible reason for this increase could be that 
the cells were cultured to 100% confluence, and confluence is known to change gene 
expression patterns in human ASCs (Kim et al., 2014). Alternatively, a small portion of the 
cells could have spontaneously started to differentiate towards the adipocyte lineage, as 
several types of MSCs have been show capable of spontaneous differentiation (Adamzyk et 
al., 2013, Zhang and Kilian, 2013). 
5.3.3 Transcription of LEP is elevated by MDI induction 
The measured transcript levels of LEP were highest two days after induction, and 
remained stable from day 6 until the end of the experiment (Fig 4.6.C.). The transcription 
levels of LEP were continuously higher in MDI and MDI+ROSI exposed cells than in BM 
cultured cells (average of 3 times higher from day 6 to day 14) indicating that MDI induction 
elevates transcription of LEP. From day six and throughout the experiment levels of LEP 
appeared to be independent of ROSI. These results were contradictive to results in a previous 
study, where the transcript levels of LEP in 3T3-L1 cells increased over time during 
induction by MDI and further increased by MDI supplemented with troglitazone, another 
PPARγ ligand (Kamstra et al., 2014).  
To get a better understanding of how the expression of leptin change during adipogenesis 
it would be interesting to measure the amount of leptin released into the media during 
adipogenesis, which have been done in several other studies, using 3T3-L1 cells or human 
ASCs (Taxvig et al., 2012, Arsenescu et al., 2008, Rodriguez et al., 2005). An interesting 
observation is that it has been shown that the amount of secreted leptin can increase even 
though transcript levels remain unchanged (Howell and Mangum, 2011). 
5.4 EXPOSURE TO CONTAMINANTS SHOWED THAT pbASCs CAN BE 
USED TO STUDY ADIPOGENESIS 
One of the main goals of this study was to develop an in vitro method to study effects of 
contaminants on adipogenesis in polar bears. We chose to use known endocrine disrupting 
chemicals (EDCs), mono(2-ethylexyl)phatalate (MEHP) and bisphenol A (BPA) , in order  
to evaluate the results in comparison with previous findings. 
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PbASCs were exposed to MEHP or BPA for 14 days in BM (50 µM MEHP or BPA) or 
MDI medium (10 or 50 µM MEHP, or 10 or 50 µM BPA), before analysis of lipid content 
and gene expression were conducted. Results from ORO staining and real-time Q-PCR were 
consistent with each other. 
5.4.1 EXPOSURE TO MEHP INDUCED ADIPOCYTE DIFFERENTIATION OF 
pbASCs 
In the pooled results of the two conducted experiments the lipid content of pbASCs 
exposed to 50 µM MEHP, both in BM and MDI medium, were significantly higher (P<0.05) 
compared to non-exposed control cells (Fig 4.7.A.). 10 µM MEHP in MDI medium led to 
an increased lipid content in experiment A (Fig 4.7.B.), but not in experiment B (Fig. 4.7.C.). 
This is noteworthy because there were encountered some problems during the Oil Red O 
staining (as elaborated in 5.5.2) of experiment B, which may have led to unrepresentative 
results.  
From the transcript level analysis it was found that the transcript levels of PPARγ and 
FABP4 in all cells exposed to MEHP (BM+50 M MEPH, MDI+10 M MEHP and MDI+50 
µM MEHP) were significantly higher compared to the non-exposed control cells (Fig. 4.8.A 
and B.). This could indicate that MEHP is a PPARγ ligand also in polar bears. MEHP had 
no effect on transcript levels of LEP (Fig. 4.8.C.). A possible explanation for this is that 
transcript levels of LEP in polar bear do not reflect the degree of adipogenic conversion 
taken place. This is based on the findings from the experiment were transcript levels of LEP 
were measured at different stages of adipogenic differentiation (4.4, 5.3). Here we found that 
the gene expression of LEP were independent of ROSI from day 6 and throughout the 
experiment, hence it is possible that LEP expression is independent of MEHP exposure as 
well.  
Exposure to MEHP, both at 50 and 10 µM, led to an increase in both lipid content and 
transcription levels of PPARγ and FABP4. Thus indicating that exposure to MEHP at these 
concentrations may induce adipogenesis in polar bear ASCs, which is in accordance with 
previous findings using 3T3-L1 cells (Feige et al., 2007, Hurst and Waxman, 2003, Taxvig 
et al., 2012). However, it was not possible to compare if the induction was at a higher, lower 
or similar level as in these studies, due to difference in differentiation protocol and exposure 
concentrations.  
A previous study where 3T3-L1 cells were induced by another PPARγ ligand 
(troglitazone, 1 µM), found that this led to an induction of non-induced cells after exposure 
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of troglitazone for one week (Grun et al., 2006). As MEHP induced adipogenesis in non-
induced cells, this could be another indication of MEHP as a PPARγ ligand also in polar 
bears. 
5.4.2 EXPOSURE TO BPA DID NOT INDUCE ADIPOCYTE DIFFERENTIATION 
OF pbASCs 
No change in lipid content by exposure to BPA was detected in the pooled results of the 
two conducted experiments (Fig. 4.7.A.). But, results from Experiment A indicated that cells 
induced by MDI medium supplemented with BPA (10 or 50 µM) had a lower lipid content 
than cells non-exposed cells in MDI medium (Fig 4.7.B.). This is noteworthy for the same 
reasons as explained in the previous section.  
The transcript level analysis indicated that cells subjected to BM+50 µM BPA had an 
increased transcript level (1.24-fold) of PPARγ, while cells subjected to MDI+50 µM BPA 
had a decreased transcript level (2.3-fold), compared to non-exposed controls (Fig. 4.8.A.). 
No significant change in transcript levels of FABP4 was found (Fig. 4.8.B.). Transcript 
levels of LEP were lower in cells exposed to BPA, compared to non-exposed control cells 
(Fig. 4.8.C.), indicating that BPA exposure decrease transcription of LEP. 
Exposure to BPA did not affect lipid content in the pooled results from the Oil Red O 
staining, nor result in any strongly marked changes in transcript levels of PPARγ or FABP4, 
indicating that BPA did not increase adipogenic differentiation of pbASCs. This is in 
accordance with previous study by Chamorro-Garcia which found that BPA induced 
adipocyte differentiation of 3T3-L1 cells, but not in BMSCs derived from human or mouse 
(Chamorro-Garcia et al., 2012). 
However, results from the lipid quantification of experiment A indicated that BPA 
decreased adipocyte differentiation of cells induced by MDI (Fig. 4.7.B.). An interesting 
study by Biemann et al. (2012) found that there were a decrease in adipogenic differentiation 
in BMSCs derived from mouse, when the cells were exposed to BPA during undifferentiated 
growth, , i.e. before confluence. This indicated that the effect of BPA depends on when the 
cells are exposed, and that BPA affects the level of adipogenic differentiation by reducing 
commitment of BMSCs to the adipogenic lineage (Biemann et al., 2012). It would be 
interesting to see if this is the case in pbASCs as well. 
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5.5 FACTORS THAT MAY HAVE AFFECTED THE REPRODUCIBILITY AND 
RELIABILITY OF THE FINDINGS IN THIS STUDY 
5.5.1 Primary cultures of MSCs are heterogeneous and donor dependent 
There are some advantages and disadvantages of using primary cultures of mesenchymal 
stem cells (MSCs) or cell lines (such as 3T3-L1) to study adipogenesis and effects of 
pollutants on this process. Cell lines can be better controlled, as they contain a homogenous 
cell population at the same stage of differentiation, while cultures of MSCs are 
heterogeneous, containing other cell types, and cells at different stages of  their life span.   
An advantage of using stem cells isolated from tissue, such as adipose, is that they may 
reflect more accurately the conditions in vivo (Butterwith, 1994).   
In this study all the pbASCs used are derived from the same polar bear, a ten year old 
male. It is known that the differentiation capacity of primary cultures is donor dependent and 
decreases with age (Choudhery et al., 2014, Gregoire et al., 1995, Kirkland et al., 1990). 
Also, the polar bear originated from Svalbard. Polar bears from this area are considered 
to be especially at risk for POP exposure and associated effects (Letcher et al., 2010). Hence, 
it is possible that exposure to contaminants already have affected the isolated cells in some 
manner. To properly evaluate effects of contaminants on adipogenesis in pbASCs, 
experiment should be conducted on pbASCs derived from multiple polar bears with different 
contaminant exposure.  
5.5.2 The protocol used for Oil red O quantification of lipid content can lead to 
several sources of error 
Adipogenic differentiation of pbASCs was quantified by measuring the lipid content in 
pbASCs, as measured absorbance in eluates from Oil Red O (ORO) staining. Several 
problems were encountered using this method.  
First, it was observed that when the cells undergo adipogenic differentiation the cells had 
an increased tendency to detach from the culture plate. This observation is in accordance 
with literature (Zebisch et al., 2012, Fink and Zachar, 2011). A potential loss of cells makes 
comparison of lipid content in different wells challenging, due to different number of cells 
eluting Oil Red O to the lysates. Also, this phenomenon can strongly influence the 
reproducibility of the experiments, because a loss of differentiated cells will affect the 
amount of ORO staining, and subsequently quantification of lipid content by absorbance 
measurements. This can lead to results that do not reflect the amount of adipogenic 
conversion taking place during the experiment accurately.  
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Second, during some experiments, small crystals of ORO were attached to the cell layer 
(Fig 4.7.D.)). The reason for these crystals remains unknown, as it did not help to prepare 
fresh stock solution, nor working solution. It was possible to remove some of the crystals 
from the samples by repetitive washing with water. But the presence of these crystals could 
lead to falsely high absorbance measurements, and subsequently to unrepresentative results.  
In addition, this method can produce a high background staining, by the presence of 
residual stain in the culture plate. High background staining is unfavorable, as it can reduce 
the ability of this method to detect differences in lipid content between different cell 
treatments. To avoid background staining it is crucial to work fast, steady and accurately, to 
limit the amount of stain attached on the culture plate. An alternative could be to quantify 
the lipid content directly (e.g. by using an adipogenesis detection kit). Direct quantification 
is faster and requires few washing steps, thus reducing the risk of loss of differentiated cells. 
Due to time constraints a planned assessment of using an adipogenesis detection kit 
(ab102513, abcam.com) compared to ORO staining was not conducted in this study, but this 
is an option that could be considered in the future.  
5.5.3 Small sample size and no repeated experiments 
Several of the findings in this study originate from experiments that have only been 
conducted once. Cells used for lipid quantification were seeded in triplicates, while cells 
used for gene expression analysis were seeded in duplicates. For biological assays the 
general rule is that a minimum of three replicates is needed, and that the experiments should 
be repeated two to three times. Hence, to verify the findings in this study the experiments 
must be repeated. 
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6 CONCLUSIONS 
This study represents, to our knowledge, the first study to describe cultivation and 
adipogenic stimulation of adipose-tissue derived stem cells from polar bear (pbASCs). It was 
demonstrated that the pbASCs were adherent to plastic when maintained in culture, and was 
shown to be capable of adipogenic differentiation, thus fulfilling some of the requirements 
formulated by the International Society for Cellular Therapy (ISCT) for defining cells as 
multipotent mesenchymal stem cells (MSCs). 
In the present study conditions for inducing different levels of adipogenic differentiation 
of pbASCs were established. To be able to detect effects of test chemicals, an adipogenic 
induction medium (AIM) inducing a low level of adipogenic differentiation was needed. 
MDI medium, consisting of growth medium supplemented with 0.45 mM IBMX, 0.1 µM 
DEX and 1 µg/mL insulin, induced a low level of adipogenic differentiation, while addition 
of 1 µM ROSI to the MDI medium induced a high level of adipogenic differentiation in the 
pbASCs. Hence, MDI medium can be used as differentiated control with a low level of 
differentiation, which allows for discrimination of effects on adipogenesis by test chemicals, 
while MDI-ROSI can be used as a positive control in adipocyte differentiation experiments 
using pbASCs. 
The degree of adipogenic conversion in the pbASCs was reflected by the amount of 
accumulated lipids, as well as transcript levels of the adipocyte specific genes PPARγ and 
FABP4. Lipid content and transcript levels of PPARγ and FABP4 were higher in cells 
induced by MDI+ROSI than in cells induced by MDI medium, which were in turn higher 
than in non-induced cells cultured in BM. In contrast to lipid quantification measurement 
and transcript analysis PPARγ and FABP4, the transcription levels of LEP did not reflect the 
degree of adipocyte conversion. This indicates that LEP may not be a suitable target gene 
for investigating adipogenic induction in pbASCs. 
Exposure to a known EDC, MEHP, induced adipocyte differentiation of pbASCs, both 
in non-induced cells cultured in BM and in cells induced by MDI medium. MEHP is known 
to be a PPARγ ligand, and the results indicated that MEHP induces adipogenesis also in 
pbASCs through PPARγ activation. 
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No increase in adipogenic differentiation was found by exposure of pbASCs to BPA, 
which is in contrast with previous studies on 3T3-L1 cells from mouse. This highlights the 
necessity of using primary cells derived from the species in question 
In conclusion, this study has shown that it is possible to detect effects of environmental 
contaminants on adipocyte differentiation of pbASCs by quantification of lipid content and 
transcript level analysis, although the experiments needs to be repeated to verify the findings. 
7 FUTURE PERSPECTIVES 
In this thesis a method for detecting effects of environmental contaminants on adipocyte 
differentiation of pbASCs has been established. Using pbASCs to study effects of 
contaminants in polar bears avoids extrapolation between species, and may reflect more 
accurately the adipose tissue in vivo. Also, results from contamination studies using pbASCs 
can be of relevance to human health, as the ligand binding domain (LBD) of PPARγ is 
identical in human and polar bear (Routti et al., unpublished). 
As a continuation of the work conducted in this study, the next step would be to further 
develop the in vitro method established. Further work suggestions include: 
• Investigating the possibility of shortening the induction period of pbASCs. In this 
study visual sign of triglyceride accumulation was visible after only seven days 
of induction, and levels of PPARγ and FABP4 were highly elevated six days after 
induction. 
• Develop a method for measuring levels of secreted leptin from pbASCs in the 
media, as this would probably reflect the expression of leptin more accurately. 
Also, many studies have measured the amount of leptin in media during exposure 
studies, allowing for comparison with previous findings. 
• Repeat the experiments on pbASCs derived from other polar bears. 
• Assess if measuring lipid content directly can provide more reliable and 
reproducible results than Oil red O staining. 
When this method has been validated and optimized, a natural continuation of the work 
would be to expose pbASCs to environmental contaminants at the levels found in polar 
bears, in single exposures and in mixtures, to evaluate their effect on adipogenesis. Also, to 
increase the understanding of how environmental contaminants affect adipogenesis in polar 
bear it could be interesting to conduct experiments which investigate the mechanic effects 
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of the contaminants. One possibility could be to use microarray assays, as these can measure 
the expression levels of a large number of genes simultaneously.  
 Further, one of the characteristics of mesenchymal stem cells (MSCs) is the ability 
to differentiate adipocytes, osteoblasts, and chondroblasts. Thus, the ability of pbASCs of 
osteogenic and chondrogenic differentiation should be investigated, and perhaps pbASCs 
can function as an in vitro model for effects of environmental contamination on osteogenic 
and chondrogenic differentiation as well. 
As a part of the “Contaminant effects on energetics” project the effect of contaminant 
mixtures, consisting of contaminants at the composition and concentration found in polar 
bear adipose tissue, on adipogenesis in 3T3-L1 cells have been conducted. Although 3T3-
L1 cells are a well-studied model of adipogenesis they may not be able to accurately reflect 
the effects of contaminants on adipocyte differentiation in MSCs. The 3T3-L1 cells are a 
continuous cell line, and differentiation properties may differ from that of stem cells isolated 
from tissue (Bjorntorp et al., 1980, Qian et al., 2010). For example, in the present study BPA 
did not induce adipocyte differentiation, although it is known to do so in 3T3-L1 cells. It is 
possible that BPA is not the only EDC that affects pbASCs differently than 3T3-L1 cells. 
This could be investigated by comparing results from exposure studies on pbASCs and 3T3-
L1 cells, or by comparing to previously conducted studies using 3T3-L1 cells.  
PbASCs as an in vitro model for effects of environmental contaminants on adipogenesis 
can provide valuable information on how contaminant exposure can affect energy 
homeostasis in polar bears. Exposure studies using in vitro models allow us to evaluate 
mechanisms of contaminants and examine dose-response relationships (DelRaso, 1993). 
Thus, the use of in vitro studies can provide information that cannot be obtained by field or 
correlation studies of polar bears. By combining findings from in vitro and field studies it is 
possible to gain a more comprehensive picture of effects of environmental contaminants and 
climate warming on polar bear health and survival. 
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SUITABLE CULTURE PLATE SIZES FOR EXPERIMENTS 
It was desirable to look at the possibility of using 12-well culturing plates instead of 
6-well culturing plates, which is very commonly used for both Oil Red O staining and 
RNA extraction, as this will require less than half the amount of cells needed for each 
well. We have a limited quantity of polar bear ASCs available, and it is therefore 
desirable to reduce the number of cells needed for each experiment. 
 
Oil red O staining 
Confluent cells were cultured in 6- or 12-well culturing plated for two weeks in BM, 
MDII50 or MDII50R medium (Table 3.1), and subsequently stained with Oil Red O 
(ORO). ORO was eluted by incubating the 6-well plates in 1 mL of 100 % isopropanol 
for 10 minutes, while 12-well plates was incubated in 0.5 mL 100 % isopropanol. The 
absorbance was measured at 500 nm.  
The results showed the same trends in both the 6- and 12- well samples, but the 
measured lipid content was a bit lower in the cells cultivated in 12-well plates (Fig. A.1.). 
Based on these results it was decided to use 12- well culturing plates for exposure 
experiments. 
 
Figure A.1 Effect of well size on measured fold induction 
PbASCs in 6- or 12-well culturing plates were incubated with MDII50 (Table 3.1.) supplemented 
with 0.2 % DMSO or MDII50R for two weeks, and subsequently fixated and stained with Oil 
Red O (ORO). The absorbance of eluted ORO was measured at 500nm to quantify lipid content.  
The experiment was conducted in duplicates. 
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Real time Q-PCR analysis 
Cells were cultured in 6- or 12-well culturing plates for two and 14 days in BM, MDI 
or MDI+1 µM ROSI (Table 3.2.). RNA was extracted, and the concentration measured 
using Nanodrop ®. Over twice as much RNA could be extracted from 6-well plates 
compared to 12-well plates (Fig. A.2.).  
For cDNA synthesis 0.5 µg of RNA is needed, and the lowest amount of RNA 
extracted in any of the 12-well plates were 1.4 µg (BM, 14 days), which is almost three 
times the amount needed. Also here it was decided that 12- well culturing plates would 
be used for exposure experiments, as this would require much fewer cells. 
 
Figure A.2 Effect of well size on measured fold induction 
PbASCs were incubated with MDI (Table 3.2.) supplemented with 0.2 % DMSO or 1 µM ROSI 
for two days, and subsequently RNA was extracted. The absorbance of eluted ORO was 
measured at 500nm to quantify lipid content.  The experiment was conducted in 6-well 
duplicates. Abbrevations: 
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PREPARATION OF STANDARD MATERIAL FOR REAL-TIME Q-PCR 
PCR products consisting of LEP or YWHAZ gene sequence fragments were ligated 
into cloning vectors, transformed into bacteria for cloning, and subsequently purified and 
sequenced (Fig. B.1.). Only the molecular cloning results for the LEP PCR products will 
be shown, as the results for obtaining plasmids containing the YWHAZ gene sequence 
was equivalent to these results. 
 
 
Figure B.1 Strategy for obtaining plasmids containing selected gene sequence fragments. 
 
RNA extraction, purification and quality assessment 
PbASCs was cultured in BM, MDI or MDI+1 µM ROSI (Table 3.2.), following the 
general adipogenic induction protocol (3.3.1). Total RNA was extracted from the cells, 
and spectrophotometric measurements and denaturing AGE was conducted (3.5.1) 
The A260/280 ratio suggested that the RNA were without contamination of proteins 
(Table B.1.). Denaturing AGE indicated that the integrity of the total RNA was 
conserved, as 28S and 18S ribosomal RNA was clearly visible as two strong bands (Fig. 
B.2.)  
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Table B.1. Spectrophotometric measurements of concentration and purity of extracted total 
RNA from duplicate samples using NanoDrop. 
Media 
Sample 
No. [ng/uL]  A260/280  
Sample 
No. [ng/uL]  A260/280 
BM 1 43.2 2.1 2 46.0 2.1 
MDI 1 74.2 2.1 2 77.8 2.1 
MDI+ROSI 1 91.0 2.1 2 106.3 2.1 
 
 
Figure B.2. Evaluation of extracted and purified total RNA by denaturing AGE.  
One hundred ng of total RNA extracted from pbASCs, which had been cultures for two weeks in 
media (BM, MDI or MDI+ROSI), were subjected to denaturing AGE (0.7 % agarose, 0.5 x TBE 
buffer), along with 100 ng 2-log DNA ladder. 
 
Synthesis of complementary DNA and amplification of the LEP fragment 
Complementary DNA (cDNA) was synthesized from RNA (3.5.2), originating from 
MDI+ROSI sample number 1 (Table B.1.). Subsequently the LEP gene sequence fragment 
was amplified by PCR (3.5.3), using LEP specific primers (Table 2.9.). 
The amplification product was approximately 200 bp (Fig. B.3), which coincide with the 
theoretical size of 171 bp. The non template control (NTC) yielded no such product, 
indicating that no contamination had occurred. A control reaction, where no reverse 
transcriptase (no-RT) was added during cDNA synthesis, yielded no PCR product at 200 bp, 
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3 
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indicating that the total RNA was free from genomic DNA contamination. The PCR 
seemingly yielded one product, as only one single product band was present on the agarose 
gel. This is an indication of high primer specificity.  
 
Figure B.3 Evaluation of amplification of the LEP fragment.  
PCR, using cDNA as a template, was performed with LEP gene sequence specific primers. 
For each sample reaction a no template control was prepared. A no reverse transcriptase (no-
RT), sample was also prepared The samples were subjected to AGE (1 % agarose, 0.5 x TBE 
buffer), along with 100 ng 2-log DNA ladder. 
 
Preparation of plasmids containing the amplified LEP fragment 
The LEP fragment was ligated into a cloning vector, and the recombinant DNA was 
inserted into bacteria by transformation (3.5.6). To confirm that ampicillin resistant colonies 
contained the recombinant DNA a colony PCR was conducted (3.5.7). 
PCR products of approximately 400 bp indicated that the plasmids used for template in 
the reaction contained the LEP fragment, as the theoretical size of the amplification product 
was 390 bp (Fig B.4.). By comparing the sequencing results from Sanger sequencing (3.5.9) 
to the theoretical sequence, it was confirmed that the amplified sequence was the intended 
LEP sequence. 
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Figure B.4. Identification of transformed bacteria containing plasmids with the LEP gene 
sequence. Eight ampicillin resistant bacteria colonies were subjected to colony PCR to identify 
which of the colonies that contained plasmids ligated with the amplified LEP fragment, using vector 
specific primers. A control plasmid (pSC_A-ADIPOQ) was used as a positive control, and a no 
template control was also prepared. The samples were subjected to AGE (1 % agarose, 0.5 x TBE 
buffer), along with 100 ng 2-log DNA ladder. 
 
Linearization of plasmids (pSC-A-LEP) 
Plasmids containing the LEP gene sequence fragment were linearized using NotI 
restriction enzyme (3.5.10). By subjecting the samples to AGE it was confirmed that the 
digestion was complete (Fig. B.5.). The theoretical size of the plasmids were 4441 bp, and 
the digested samples produced only one band at approximately 4500 bp, indicating that all 
of the plasmids had been linearized. Undigested samples yielded three distinct bands, one 
for each possible shape of the plasmid. The strong band at approximately 3500 bp represents 
the intact plasmids, as these are in a supercoiled state and therefore runs faster through the 
gel. Plasmids with one nicked DNA strand are located in the upper band, at approximately 
7000 bp, as these run slower through the gel due to their circular shape. 
          Colony                  
1  2   3   4   5   6   7  8   +    - 
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Figure B.5. Plasmids linearized by restriction enzymes.  
pSC-A-LEP plasmids were linearized using the restriction enzyme Not I. The restriction digestion 
samples, and undigested control samples, were subjected to AGE (0.4 % agarose, 0.5 x TBE buffer), 
along with 100 ng 2-log DNA ladder. 
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EVALUATION OF STABILITY OF THE REFERENCE GENES YWHAZ AND PPIA 
ACROSS EXPERIMENTAL CONDITIONS 
The stability of the reference genes tyrosine 3/tryptophan 5-monooxygenase activation 
protein (YWHAZ) and cyclophilin A (PPIA) were evaluated by evaluating variance in the CT 
values for all YWHAZ and PPIA samples originating from the experiment where the gene 
expression of selected target genes during adipogenic differentiation were investigated 
(n=23, one sample was omitted as no CT value was obtained for that sample) using 
RefFinder. RefFinder uses software from four of the most common methods used to evaluate 
gene stability, including Genorm, NormFinder, and BestKeeper. All methods showed similar 
results. The results from BestKeeper were as follows: Mean of CT of YWHAZ samples was 
20.35, with a SD of 0.26, while the mean CT and SD for PPIA samples were 18.78 and 0.19. 
The Pearson correlation coefficient and P-value were 0.857 and 0.001 for YWHAZ samples, 
and 0.730 and 0.001 for PPIA samples, respectively. These results indicate that the reference 
genes were stable across experimental conditions  (Pfaffl et al., 2004). Thus, YWHAZ and 
PPIA were considered suitable reference genes for studying adipogenesis in pbASCs. 
 
STANDARD CURVES USED IN REAL-TIME Q-PCR 
Standard curves were created by serial dilutions of linearized pSC-A plasmids containing 
the selected gene sequences (PPARγ, FABP4, LEP, YWHAZ or PPIA). The biomath 
calculator from Promega was used to convert the spectrophotometrically measured plasmid 
concentration (Nanodrop®) from ng/µL to pmol/µL. From this the number of molecules per 
µL was calculated, and subsequently dilutions containing the desired start concentration (e.g. 
2*108 molecules/µL) were made. Serial dilutions were carried out with a dilution factor of 
ten, using ultra-pure water. 1:10, 1:20 and 1:40 dilutions of pooled cDNA was also 
measured, to evaluate which dilution factor that was most suitable to use. Samples were run 
as previously described (3.6). 
 It was decided that a 1:10 dilution of cDNA samples could be used for all real-time Q-
PCR analysis. 
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Figure C.1. Amplification, standard and melting curves of the pSC-A plasmid containing the 
pbYWHAZ gene fragment in a dilution series of 106-104 molecules. Amplification efficiency was 
1.877. 
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Figure C.2. Amplification, standard and melting curves of the pSC-A plasmid containing the 
pbPPIA gene fragment in a dilution series of 107-105 molecules Amplification efficiency was 
1.894. 
APPENDIX C 
xxi 
 
 
Figure C.3. Amplification, standard and melting curves of the pSC-A plasmid containing the 
pbPPARγ gene fragment in a dilution series of 103, 105 and 108 molecules. Amplification 
efficiency was 1.949. 
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Figure C.4. Amplification, standard and melting curves of the pSC-A plasmid containing the 
pbFABP4 gene fragment in a dilution series of 103, 105 and 108 molecules Amplification 
efficiency was 1.857. 
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Figure C.5. Amplification, standard and melting curves of the pSC-A plasmid containing the 
pbLEP gene fragment in a dilution series of 103, 105 and 108 molecules. Amplification efficiency 
was 1.885. 
